{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["alternative treatment options", "urinary tract infections", "uropathogenic Escherichia coli"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37445714", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "17"}, "DateRevised": {"Year": "2023", "Month": "07", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10537", "10.3390/ijms241310537"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "13", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "23"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Urinary Tract Infections Caused by Uropathogenic <i>Escherichia coli</i>: Mechanisms of Infection and Treatment Options.", "Abstract": {"AbstractText": ["Urinary tract infections (UTIs) are common bacterial infections that represent a severe public health problem. They are often caused by <i>Escherichia coli</i> (<i>E. coli</i>), <i>Klebsiella pneumoniae</i> (<i>K. pneumonia</i>), <i>Proteus mirabilis</i> (<i>P. mirabilis</i>), <i>Enterococcus faecalis</i> (<i>E. faecalis</i>), and <i>Staphylococcus saprophyticus</i> (<i>S. saprophyticus</i>). Among these, uropathogenic <i>E. coli</i> (UPEC) are the most common causative agent in both uncomplicated and complicated UTIs. The adaptive evolution of UPEC has been observed in several ways, including changes in colonization, attachment, invasion, and intracellular replication to invade the urothelium and survive intracellularly. While antibiotic therapy has historically been very successful in controlling UTIs, high recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly reduce the efficacy of these treatments. Furthermore, the gradual global emergence of multidrug-resistant UPEC has highlighted the need to further explore its pathogenesis and seek alternative therapeutic and preventative strategies. Therefore, a thorough understanding of the clinical status and pathogenesis of UTIs and the advantages and disadvantages of antibiotics as a conventional treatment option could spark a surge in the search for alternative treatment options, especially vaccines and medicinal plants. Such options targeting multiple pathogenic mechanisms of UPEC are expected to be a focus of UTI management in the future to help combat antibiotic resistance."]}, "AuthorList": [{"Identifier": ["0000-0003-0556-7228"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}], "LastName": "Zhou", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": ["0000-0003-4879-7621"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}], "LastName": "Zhou", "ForeName": "Zuying", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}], "LastName": "Zheng", "ForeName": "Lin", "Initials": "L"}, {"Identifier": ["0000-0003-2074-9476"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}], "LastName": "Gong", "ForeName": "Zipeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}], "LastName": "Li", "ForeName": "Yueting", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}], "LastName": "Jin", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}], "LastName": "Huang", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, 4 Beijing Road, Guiyang 550004, China."}], "LastName": "Chi", "ForeName": "Mingyan", "Initials": "M"}], "GrantList": [{"GrantID": "82274203", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "U1812403", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "GCC(2022)031-1", "Agency": "Guizhou Science and Technology Department", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Uropathogenic Escherichia coli"}, {"QualifierName": ["drug therapy", "microbiology"], "DescriptorName": "Escherichia coli Infections"}, {"QualifierName": ["drug therapy", "microbiology"], "DescriptorName": "Urinary Tract Infections"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Bacterial Infections"}, {"QualifierName": [], "DescriptorName": "Urinary Tract"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015;13:269\u2013284. doi: 10.1038/nrmicro3432.", "ArticleIdList": ["10.1038/nrmicro3432", "PMC4457377", "25853778"]}, {"Citation": "O\u2019Brien V.P., Hannan T.J., Nielsen H.V., Hultgren S.J. Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol. Spectr. 2016;4:589\u2013646. doi: 10.1128/microbiolspec.UTI-0013-2012.", "ArticleIdList": ["10.1128/microbiolspec.UTI-0013-2012", "PMC4887100", "26999391"]}, {"Citation": "Foxman B. Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. N. Am. 2014;28:1\u201313. doi: 10.1016/j.idc.2013.09.003.", "ArticleIdList": ["10.1016/j.idc.2013.09.003", "24484571"]}, {"Citation": "Tandogdu Z., Wagenlehner F.M. Global epidemiology of urinary tract infections. Curr. Opin. Infect. Dis. 2016;29:73\u201379. doi: 10.1097/QCO.0000000000000228.", "ArticleIdList": ["10.1097/QCO.0000000000000228", "26694621"]}, {"Citation": "Tullus K., Shaikh N. Urinary tract infections in children. Lancet. 2020;395:1659\u20131668. doi: 10.1016/S0140-6736(20)30676-0.", "ArticleIdList": ["10.1016/S0140-6736(20)30676-0", "32446408"]}, {"Citation": "Fu Z., Liska D., Talan D., Chung M. Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis. J. Nutr. 2017;147:2282\u20132288. doi: 10.3945/jn.117.254961.", "ArticleIdList": ["10.3945/jn.117.254961", "29046404"]}, {"Citation": "Anger J., Lee U., Ackerman A.L., Chou R., Chughtai B., Clemens J.Q., Hickling D., Kapoor A., Kenton K.S., Kaufman M.R., et al. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. J. Urol. 2019;202:282\u2013289. doi: 10.1097/JU.0000000000000296.", "ArticleIdList": ["10.1097/JU.0000000000000296", "31042112"]}, {"Citation": "Schneeberger C., Geerlings S.E., Middleton P., Crowther C.A. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst. Rev. 2015;2015:Cd009279. doi: 10.1002/14651858.CD009279.pub3.", "ArticleIdList": ["10.1002/14651858.CD009279.pub3", "PMC6457953", "26221993"]}, {"Citation": "Matthews S.J., Lancaster J.W. Urinary tract infections in the elderly population. Am. J. Geriatr. Pharmacother. 2011;9:286\u2013309. doi: 10.1016/j.amjopharm.2011.07.002.", "ArticleIdList": ["10.1016/j.amjopharm.2011.07.002", "21840265"]}, {"Citation": "Jung C., Brubaker L. The etiology and management of recurrent urinary tract infections in postmenopausal women. Climacteric. 2019;22:242\u2013249. doi: 10.1080/13697137.2018.1551871.", "ArticleIdList": ["10.1080/13697137.2018.1551871", "PMC6629580", "30624087"]}, {"Citation": "Becknell B., Schober M., Korbel L., Spencer J.D. The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev. Anti-Infect. Ther. 2015;13:81\u201390. doi: 10.1586/14787210.2015.986097.", "ArticleIdList": ["10.1586/14787210.2015.986097", "PMC4652790", "25421102"]}, {"Citation": "Sim\u00f5es E., Silva A.C., Oliveira E.A., Mak R.H. Urinary tract infection in pediatrics: An overview. J. Pediatr. (Rio. J.) 2020;96:65\u201379. doi: 10.1016/j.jped.2019.10.006.", "ArticleIdList": ["10.1016/j.jped.2019.10.006", "PMC9432043", "31783012"]}, {"Citation": "Keren R., Shaikh N., Pohl H., Gravens-Mueller L., Ivanova A., Zaoutis L., Patel M., de Berardinis R., Parker A., Bhatnagar S., et al. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring. Pediatrics. 2015;136:e13\u2013e21. doi: 10.1542/peds.2015-0409.", "ArticleIdList": ["10.1542/peds.2015-0409", "PMC4485012", "26055855"]}, {"Citation": "Mattoo T.K., Shaikh N., Nelson C.P. Contemporary Management of Urinary Tract Infection in Children. Pediatrics. 2021;147:e2020012138. doi: 10.1542/peds.2020-012138.", "ArticleIdList": ["10.1542/peds.2020-012138", "33479164"]}, {"Citation": "Silverman J.A., Schreiber H.L.T., Hooton T.M., Hultgren S.J. From physiology to pharmacy: Developments in the pathogenesis and treatment of recurrent urinary tract infections. Curr. Urol. Rep. 2013;14:448\u2013456. doi: 10.1007/s11934-013-0354-5.", "ArticleIdList": ["10.1007/s11934-013-0354-5", "PMC3797163", "23832844"]}, {"Citation": "Hannan T.J., Totsika M., Mansfield K.J., Moore K.H., Schembri M.A., Hultgren S.J. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol. Rev. 2012;36:616\u2013648. doi: 10.1111/j.1574-6976.2012.00339.x.", "ArticleIdList": ["10.1111/j.1574-6976.2012.00339.x", "PMC3675774", "22404313"]}, {"Citation": "Nielubowicz G.R., Mobley H.L. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 2010;7:430\u2013441. doi: 10.1038/nrurol.2010.101.", "ArticleIdList": ["10.1038/nrurol.2010.101", "20647992"]}, {"Citation": "Terlizzi M.E., Gribaudo G., Maffei M.E. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Front. Microbiol. 2017;8:1566. doi: 10.3389/fmicb.2017.01566.", "ArticleIdList": ["10.3389/fmicb.2017.01566", "PMC5559502", "28861072"]}, {"Citation": "Dhakal B.K., Kulesus R.R., Mulvey M.A. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur. J. Clin. Investig. 2008;38:2\u201311. doi: 10.1111/j.1365-2362.2008.01986.x.", "ArticleIdList": ["10.1111/j.1365-2362.2008.01986.x", "18616559"]}, {"Citation": "Spaulding C.N., Hultgren S.J. Adhesive Pili in UTI Pathogenesis and Drug Development. Pathogens. 2016;5:30. doi: 10.3390/pathogens5010030.", "ArticleIdList": ["10.3390/pathogens5010030", "PMC4810151", "26999218"]}, {"Citation": "Totsika M., Moriel D.G., Idris A., Rogers B.A., Wurpel D.J., Phan M.D., Paterson D.L., Schembri M.A. Uropathogenic Escherichia coli mediated urinary tract infection. Curr. Drug Targets. 2012;13:1386\u20131399. doi: 10.2174/138945012803530206.", "ArticleIdList": ["10.2174/138945012803530206", "22664092"]}, {"Citation": "Agarwal J., Srivastava S., Singh M. Pathogenomics of uropathogenic Escherichia coli. Indian J. Med. Microbiol. 2012;30:141\u2013149. doi: 10.4103/0255-0857.96657.", "ArticleIdList": ["10.4103/0255-0857.96657", "22664427"]}, {"Citation": "Ribi\u0107 R., Me\u0161trovi\u0107 T., Neuberg M., Kozina G. Effective anti-adhesives of uropathogenic Escherichia coli. Acta Pharm. 2018;68:1\u201318. doi: 10.2478/acph-2018-0004.", "ArticleIdList": ["10.2478/acph-2018-0004", "29453908"]}, {"Citation": "Pakharukova N., McKenna S., Tuittila M., Paavilainen S., Malmi H., Xu Y., Parilova O., Matthews S., Zavialov A.V. Archaic and alternative chaperones preserve pilin folding energy by providing incomplete structural information. J. Biol. Chem. 2018;293:17070\u201317080. doi: 10.1074/jbc.RA118.004170.", "ArticleIdList": ["10.1074/jbc.RA118.004170", "PMC6222105", "30228191"]}, {"Citation": "Kuehn M.J., Heuser J., Normark S., Hultgren S.J. P pili in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips. Nature. 1992;356:252\u2013255. doi: 10.1038/356252a0.", "ArticleIdList": ["10.1038/356252a0", "1348107"]}, {"Citation": "Phan G., Remaut H., Wang T., Allen W.J., Pirker K.F., Lebedev A., Henderson N.S., Geibel S., Volkan E., Yan J., et al. Crystal structure of the FimD usher bound to its cognate FimC-FimH substrate. Nature. 2011;474:49\u201353. doi: 10.1038/nature10109.", "ArticleIdList": ["10.1038/nature10109", "PMC3162478", "21637253"]}, {"Citation": "Waksman G. Structural and Molecular Biology of a Protein-Polymerizing Nanomachine for Pilus Biogenesis. J. Mol. Biol. 2017;429:2654\u20132666. doi: 10.1016/j.jmb.2017.05.016.", "ArticleIdList": ["10.1016/j.jmb.2017.05.016", "28551336"]}, {"Citation": "Chen S.L., Hung C.S., Xu J., Reigstad C.S., Magrini V., Sabo A., Blasiar D., Bieri T., Meyer R.R., Ozersky P., et al. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: A comparative genomics approach. Proc. Natl. Acad. Sci. USA. 2006;103:5977\u20135982. doi: 10.1073/pnas.0600938103.", "ArticleIdList": ["10.1073/pnas.0600938103", "PMC1424661", "16585510"]}, {"Citation": "Behzadi P. Classical chaperone-usher (CU) adhesive fimbriome: Uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs) Folia Microbiol. 2020;65:45\u201365. doi: 10.1007/s12223-019-00719-x.", "ArticleIdList": ["10.1007/s12223-019-00719-x", "31165977"]}, {"Citation": "Ong C.L., Beatson S.A., Totsika M., Forestier C., McEwan A.G., Schembri M.A. Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species. BMC Microbiol. 2010;10:183. doi: 10.1186/1471-2180-10-183.", "ArticleIdList": ["10.1186/1471-2180-10-183", "PMC2900259", "20576143"]}, {"Citation": "Zavialov A., Zav\u2019yalova G., Korpela T., Zav\u2019yalov V. FGL chaperone-assembled fimbrial polyadhesins: Anti-immune armament of Gram-negative bacterial pathogens. FEMS Microbiol. Rev. 2007;31:478\u2013514. doi: 10.1111/j.1574-6976.2007.00075.x.", "ArticleIdList": ["10.1111/j.1574-6976.2007.00075.x", "17576202"]}, {"Citation": "Zhou G., Mo W.J., Sebbel P., Min G., Neubert T.A., Glockshuber R., Wu X.R., Sun T.T., Kong X.P. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: Evidence from in vitro FimH binding. J. Cell Sci. 2001;114:4095\u20134103. doi: 10.1242/jcs.114.22.4095.", "ArticleIdList": ["10.1242/jcs.114.22.4095", "11739641"]}, {"Citation": "Eto D.S., Jones T.A., Sundsbak J.L., Mulvey M.A. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 2007;3:e100. doi: 10.1371/journal.ppat.0030100.", "ArticleIdList": ["10.1371/journal.ppat.0030100", "PMC1914067", "17630833"]}, {"Citation": "Mossman K.L., Mian M.F., Lauzon N.M., Gyles C.L., Lichty B., Mackenzie R., Gill N., Ashkar A.A. Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand. J. Immunol. 2008;181:6702\u20136706. doi: 10.4049/jimmunol.181.10.6702.", "ArticleIdList": ["10.4049/jimmunol.181.10.6702", "18981086"]}, {"Citation": "Behzadi E., Behzadi P. The role of toll-like receptors (TLRs) in urinary tract infections (UTIs) Cent. Eur. J. Urol. 2016;69:404\u2013410.", "ArticleIdList": ["PMC5260452", "28127459"]}, {"Citation": "Spaulding C.N., Klein R.D., Ruer S., Kau A.L., Schreiber H.L., Cusumano Z.T., Dodson K.W., Pinkner J.S., Fremont D.H., Janetka J.W., et al. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist. Nature. 2017;546:528\u2013532. doi: 10.1038/nature22972.", "ArticleIdList": ["10.1038/nature22972", "PMC5654549", "28614296"]}, {"Citation": "Lund B., Lindberg F., Marklund B.I., Normark S. The PapG protein is the alpha-D-galactopyranosyl-(1----4)-beta-D-galactopyranose-binding adhesin of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA. 1987;84:5898\u20135902. doi: 10.1073/pnas.84.16.5898.", "ArticleIdList": ["10.1073/pnas.84.16.5898", "PMC298970", "2886993"]}, {"Citation": "Klemm P., Hancock V., Schembri M.A. Fimbrial adhesins from extraintestinal Escherichia coli. Environ. Microbiol. Rep. 2010;2:628\u2013640. doi: 10.1111/j.1758-2229.2010.00166.x.", "ArticleIdList": ["10.1111/j.1758-2229.2010.00166.x", "23766248"]}, {"Citation": "Langermann S., M\u00f6llby R., Burlein J.E., Palaszynski S.R., Auguste C.G., DeFusco A., Strouse R., Schenerman M.A., Hultgren S.J., Pinkner J.S., et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J. Infect. Dis. 2000;181:774\u2013778. doi: 10.1086/315258.", "ArticleIdList": ["10.1086/315258", "10669375"]}, {"Citation": "Wright K.J., Seed P.C., Hultgren S.J. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol. 2007;9:2230\u20132241. doi: 10.1111/j.1462-5822.2007.00952.x.", "ArticleIdList": ["10.1111/j.1462-5822.2007.00952.x", "17490405"]}, {"Citation": "Schaeffer A.J. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. J. Urol. 2003;170:335. doi: 10.1016/S0022-5347(05)63509-4.", "ArticleIdList": ["10.1016/S0022-5347(05)63509-4", "14567339"]}, {"Citation": "Martinez J.J., Mulvey M.A., Schilling J.D., Pinkner J.S., Hultgren S.J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 2000;19:2803\u20132812. doi: 10.1093/emboj/19.12.2803.", "ArticleIdList": ["10.1093/emboj/19.12.2803", "PMC203355", "10856226"]}, {"Citation": "Wright K.J., Hultgren S.J. Sticky fibers and uropathogenesis: Bacterial adhesins in the urinary tract. Future Microbiol. 2006;1:75\u201387. doi: 10.2217/17460913.1.1.75.", "ArticleIdList": ["10.2217/17460913.1.1.75", "17661687"]}, {"Citation": "Sarowar S., Hu O.J., Werneburg G.T., Thanassi D.G., Li H. The Escherichia coli P and Type 1 Pilus Assembly Chaperones PapD and FimC Are Monomeric in Solution. J. Bacteriol. 2016;198:2360\u20132369. doi: 10.1128/JB.00366-16.", "ArticleIdList": ["10.1128/JB.00366-16", "PMC4984555", "27353649"]}, {"Citation": "Salda\u00f1a Z., De la Cruz M.A., Carrillo-Casas E.M., Dur\u00e1n L., Zhang Y., Hern\u00e1ndez-Castro R., Puente J.L., Daaka Y., Gir\u00f3n J.A. Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium. PLoS ONE. 2014;9:e101200. doi: 10.1371/journal.pone.0101200.", "ArticleIdList": ["10.1371/journal.pone.0101200", "PMC4103759", "25036370"]}, {"Citation": "Sidaway P. Infection: Exposure to human urine decreases type 1 pili expression in uropathogenic Escherichia coli. Nat. Rev. Urol. 2015;12:422. doi: 10.1038/nrurol.2015.172.", "ArticleIdList": ["10.1038/nrurol.2015.172", "26171804"]}, {"Citation": "Greene S.E., Hibbing M.E., Janetka J., Chen S.L., Hultgren S.J. Human Urine Decreases Function and Expression of Type 1 Pili in Uropathogenic Escherichia coli. mBio. 2015;6:e00820. doi: 10.1128/mBio.00820-15.", "ArticleIdList": ["10.1128/mBio.00820-15", "PMC4488945", "26126855"]}, {"Citation": "Zav\u2019yalov V., Zavialov A., Zav\u2019yalova G., Korpela T. Adhesive organelles of Gram-negative pathogens assembled with the classical chaperone/usher machinery: Structure and function from a clinical standpoint. FEMS Microbiol. Rev. 2010;34:317\u2013378. doi: 10.1111/j.1574-6976.2009.00201.x.", "ArticleIdList": ["10.1111/j.1574-6976.2009.00201.x", "20070375"]}, {"Citation": "Conover M.S., Ruer S., Taganna J., Kalas V., De Greve H., Pinkner J.S., Dodson K.W., Remaut H., Hultgren S.J. Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic, E. coli during Chronic Infection. Cell Host Microbe. 2016;20:482\u2013492. doi: 10.1016/j.chom.2016.08.013.", "ArticleIdList": ["10.1016/j.chom.2016.08.013", "PMC5294914", "27667696"]}, {"Citation": "Chahales P., Thanassi D.G. Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria. Microbiol. Spectr. 2015;3:277\u2013329. doi: 10.1128/microbiolspec.UTI-0018-2013.", "ArticleIdList": ["10.1128/microbiolspec.UTI-0018-2013", "PMC4638162", "26542038"]}, {"Citation": "Thumbikat P., Berry R.E., Zhou G., Billips B.K., Yaggie R.E., Zaichuk T., Sun T.T., Schaeffer A.J., Klumpp D.J. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog. 2009;5:e1000415. doi: 10.1371/journal.ppat.1000415.", "ArticleIdList": ["10.1371/journal.ppat.1000415", "PMC2669708", "19412341"]}, {"Citation": "Wang H., Min G., Glockshuber R., Sun T.T., Kong X.P. Uropathogenic, E. coli adhesin-induced host cell receptor conformational changes: Implications in transmembrane signaling transduction. J. Mol. Biol. 2009;392:352\u2013361. doi: 10.1016/j.jmb.2009.06.077.", "ArticleIdList": ["10.1016/j.jmb.2009.06.077", "PMC2755582", "19577575"]}, {"Citation": "Eto D.S., Gordon H.B., Dhakal B.K., Jones T.A., Mulvey M.A. Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells. Cell Microbiol. 2008;10:2553\u20132567. doi: 10.1111/j.1462-5822.2008.01229.x.", "ArticleIdList": ["10.1111/j.1462-5822.2008.01229.x", "18754852"]}, {"Citation": "Schembri M.A., Sokurenko E.V., Klemm P. Functional flexibility of the FimH adhesin: Insights from a random mutant library. Infect. Immun. 2000;68:2638\u20132646. doi: 10.1128/IAI.68.5.2638-2646.2000.", "ArticleIdList": ["10.1128/IAI.68.5.2638-2646.2000", "PMC97470", "10768955"]}, {"Citation": "Sokurenko E.V., Courtney H.S., Maslow J., Siitonen A., Hasty D.L. Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J. Bacteriol. 1995;177:3680\u20133686. doi: 10.1128/jb.177.13.3680-3686.1995.", "ArticleIdList": ["10.1128/jb.177.13.3680-3686.1995", "PMC177083", "7601831"]}, {"Citation": "Chen S.L., Hung C.S., Pinkner J.S., Walker J.N., Cusumano C.K., Li Z., Bouckaert J., Gordon J.I., Hultgren S.J. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc. Natl. Acad. Sci. USA. 2009;106:22439\u201322444. doi: 10.1073/pnas.0902179106.", "ArticleIdList": ["10.1073/pnas.0902179106", "PMC2794649", "20018753"]}, {"Citation": "Biggel M., Xavier B.B., Johnson J.R., Nielsen K.L., Frimodt-M\u00f8ller N., Matheeussen V., Goossens H., Moons P., Van Puyvelde S. Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages. Nat. Commun. 2020;11:5968. doi: 10.1038/s41467-020-19714-9.", "ArticleIdList": ["10.1038/s41467-020-19714-9", "PMC7686366", "33235212"]}, {"Citation": "Bessaiah H., Pokharel P., Loucif H., Kulbay M., Sasseville C., Habouria H., Houle S., Bernier J., Mass\u00e9 \u00c9., Van Grevenynghe J., et al. The RyfA small RNA regulates oxidative and osmotic stress responses and virulence in uropathogenic Escherichia coli. PLoS Pathog. 2021;17:e1009617. doi: 10.1371/journal.ppat.1009617.", "ArticleIdList": ["10.1371/journal.ppat.1009617", "PMC8205139", "34043736"]}, {"Citation": "Roberts K.B. Urinary tract infection: Clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128:595\u2013610. doi: 10.1542/peds.2011-1330.", "ArticleIdList": ["10.1542/peds.2011-1330", "21873693"]}, {"Citation": "Norinder B.S., K\u00f6ves B., Yadav M., Brauner A., Svanborg C. Do Escherichia coli strains causing acute cystitis have a distinct virulence repertoire? Microb. Pathog. 2012;52:10\u201316. doi: 10.1016/j.micpath.2011.08.005.", "ArticleIdList": ["10.1016/j.micpath.2011.08.005", "22023989"]}, {"Citation": "O\u2019Brien V.P., Hannan T.J., Schaeffer A.J., Hultgren S.J. Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr. Opin. Infect. Dis. 2015;28:97\u2013105. doi: 10.1097/QCO.0000000000000130.", "ArticleIdList": ["10.1097/QCO.0000000000000130", "PMC4365976", "25517222"]}, {"Citation": "Ishitoya S., Yamamoto S., Mitsumori K., Ogawa O., Terai A. Non-secretor status is associated with female acute uncomplicated pyelonephritis. BJU Int. 2002;89:851\u2013854. doi: 10.1046/j.1464-410X.2002.02782.x.", "ArticleIdList": ["10.1046/j.1464-410X.2002.02782.x", "12010227"]}, {"Citation": "Sauer F.G., Mulvey M.A., Schilling J.D., Martinez J.J., Hultgren S.J. Bacterial pili: Molecular mechanisms of pathogenesis. Curr. Opin. Microbiol. 2000;3:65\u201372. doi: 10.1016/S1369-5274(99)00053-3.", "ArticleIdList": ["10.1016/S1369-5274(99)00053-3", "10679419"]}, {"Citation": "La Combe B., Clermont O., Messika J., Eveillard M., Kouatchet A., Lasocki S., Corvec S., Lakhal K., Billard-Pomares T., Fernandes R., et al. Pneumonia-Specific Escherichia coli with Distinct Phylogenetic and Virulence Profiles, France, 2012\u20132014. Emerg. Infect. Dis. 2019;25:710\u2013718. doi: 10.3201/eid2504.180944.", "ArticleIdList": ["10.3201/eid2504.180944", "PMC6433033", "30882313"]}, {"Citation": "Werneburg G.T., Thanassi D.G. Pili Assembled by the Chaperone/Usher Pathway in Escherichia coli and Salmonella. EcoSal Plus. 2018;8:1\u201356. doi: 10.1128/ecosalplus.ESP-0007-2017.", "ArticleIdList": ["10.1128/ecosalplus.ESP-0007-2017", "PMC5940347", "29536829"]}, {"Citation": "Lane M.C., Mobley H.L. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int. 2007;72:19\u201325. doi: 10.1038/sj.ki.5002230.", "ArticleIdList": ["10.1038/sj.ki.5002230", "17396114"]}, {"Citation": "Mobley H.L., Jarvis K.G., Elwood J.P., Whittle D.I., Lockatell C.V., Russell R.G., Johnson D.E., Donnenberg M.S., Warren J.W. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: The role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. Mol. Microbiol. 1993;10:143\u2013155. doi: 10.1111/j.1365-2958.1993.tb00911.x.", "ArticleIdList": ["10.1111/j.1365-2958.1993.tb00911.x", "7968511"]}, {"Citation": "Elliott S.P., Yu M., Xu H., Haslam D.B. Forssman synthetase expression results in diminished shiga toxin susceptibility: A role for glycolipids in determining host-microbe interactions. Infect. Immun. 2003;71:6543\u20136552. doi: 10.1128/IAI.71.11.6543-6552.2003.", "ArticleIdList": ["10.1128/IAI.71.11.6543-6552.2003", "PMC219581", "14573676"]}, {"Citation": "Melican K., Sandoval R.M., Kader A., Josefsson L., Tanner G.A., Molitoris B.A., Richter-Dahlfors A. Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog. 2011;7:e1001298. doi: 10.1371/journal.ppat.1001298.", "ArticleIdList": ["10.1371/journal.ppat.1001298", "PMC3044688", "21383970"]}, {"Citation": "B\u00e4ckhed F., Als\u00e9n B., Roche N., Angstr\u00f6m J., von Euler A., Breimer M.E., Westerlund-Wikstr\u00f6m B., Teneberg S., Richter-Dahlfors A. Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation. J. Biol. Chem. 2002;277:18198\u201318205. doi: 10.1074/jbc.M111640200.", "ArticleIdList": ["10.1074/jbc.M111640200", "11877427"]}, {"Citation": "Selvarangan R., Goluszko P., Singhal J., Carnoy C., Moseley S., Hudson B., Nowicki S., Nowicki B. Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence. Infect. Immun. 2004;72:4827\u20134835. doi: 10.1128/IAI.72.8.4827-4835.2004.", "ArticleIdList": ["10.1128/IAI.72.8.4827-4835.2004", "PMC470682", "15271945"]}, {"Citation": "Qin X., Hu F., Wu S., Ye X., Zhu D., Zhang Y., Wang M. Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains. PLoS ONE. 2013;8:e61169. doi: 10.1371/journal.pone.0061169.", "ArticleIdList": ["10.1371/journal.pone.0061169", "PMC3621879", "23593422"]}, {"Citation": "Subashchandrabose S., Mobley H.L.T. Virulence and Fitness Determinants of Uropathogenic Escherichia coli. Microbiol. Spectr. 2015;3:235\u2013261. doi: 10.1128/microbiolspec.UTI-0015-2012.", "ArticleIdList": ["10.1128/microbiolspec.UTI-0015-2012", "PMC4566162", "26350328"]}, {"Citation": "Wurpel D.J., Totsika M., Allsopp L.P., Hartley-Tassell L.E., Day C.J., Peters K.M., Sarkar S., Ulett G.C., Yang J., Tiralongo J., et al. F9 fimbriae of uropathogenic Escherichia coli are expressed at low temperature and recognise Gal\u03b21-3GlcNAc-containing glycans. PLoS ONE. 2014;9:e93177. doi: 10.1371/journal.pone.0093177.", "ArticleIdList": ["10.1371/journal.pone.0093177", "PMC3966885", "24671091"]}, {"Citation": "Spurbeck R.R., Stapleton A.E., Johnson J.R., Walk S.T., Hooton T.M., Mobley H.L. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: Contribution of ygi and yad fimbriae. Infect. Immun. 2011;79:4753\u20134763. doi: 10.1128/IAI.05621-11.", "ArticleIdList": ["10.1128/IAI.05621-11", "PMC3232662", "21911462"]}, {"Citation": "Ellis T.N., Kuehn M.J. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 2010;74:81\u201394. doi: 10.1128/MMBR.00031-09.", "ArticleIdList": ["10.1128/MMBR.00031-09", "PMC2832350", "20197500"]}, {"Citation": "Wiles T.J., Kulesus R.R., Mulvey M.A. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 2008;85:11\u201319. doi: 10.1016/j.yexmp.2008.03.007.", "ArticleIdList": ["10.1016/j.yexmp.2008.03.007", "PMC2595135", "18482721"]}, {"Citation": "Vigil P.D., Alteri C.J., Mobley H.L. Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence. Infect. Immun. 2011;79:2335\u20132344. doi: 10.1128/IAI.00110-11.", "ArticleIdList": ["10.1128/IAI.00110-11", "PMC3125824", "21422188"]}, {"Citation": "Vigil P.D., Stapleton A.E., Johnson J.R., Hooton T.M., Hodges A.P., He Y., Mobley H.L. Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. mBio. 2011;2:e00066-11. doi: 10.1128/mBio.00066-11.", "ArticleIdList": ["10.1128/mBio.00066-11", "PMC3088117", "21540363"]}, {"Citation": "Engstrom M.D., Alteri C.J., Mobley H.L. A conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility. Infect. Immun. 2014;82:3644\u20133656. doi: 10.1128/IAI.01608-14.", "ArticleIdList": ["10.1128/IAI.01608-14", "PMC4187811", "24935980"]}, {"Citation": "Nesta B., Spraggon G., Alteri C., Moriel D.G., Rosini R., Veggi D., Smith S., Bertoldi I., Pastorello I., Ferlenghi I., et al. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. mBio. 2012;3:e00010-12. doi: 10.1128/mBio.00010-12.", "ArticleIdList": ["10.1128/mBio.00010-12", "PMC3324786", "22496310"]}, {"Citation": "Valle J., Mabbett A.N., Ulett G.C., Toledo-Arana A., Wecker K., Totsika M., Schembri M.A., Ghigo J.M., Beloin C. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J. Bacteriol. 2008;190:4147\u20134161. doi: 10.1128/JB.00122-08.", "ArticleIdList": ["10.1128/JB.00122-08", "PMC2446758", "18424525"]}, {"Citation": "Johnson J.R., Jelacic S., Schoening L.M., Clabots C., Shaikh N., Mobley H.L., Tarr P.I. The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect. Immun. 2005;73:965\u2013971. doi: 10.1128/IAI.73.2.965-971.2005.", "ArticleIdList": ["10.1128/IAI.73.2.965-971.2005", "PMC546986", "15664939"]}, {"Citation": "Barnhart M.M., Chapman M.R. Curli biogenesis and function. Annu. Rev. Microbiol. 2006;60:131\u2013147. doi: 10.1146/annurev.micro.60.080805.142106.", "ArticleIdList": ["10.1146/annurev.micro.60.080805.142106", "PMC2838481", "16704339"]}, {"Citation": "Kim S.M., Lee H.W., Choi Y.W., Kim S.H., Lee J.C., Lee Y.C., Seol S.Y., Cho D.T., Kim J. Involvement of curli fimbriae in the biofilm formation of Enterobacter cloacae. J. Microbiol. 2012;50:175\u2013178. doi: 10.1007/s12275-012-2044-2.", "ArticleIdList": ["10.1007/s12275-012-2044-2", "22367955"]}, {"Citation": "Nicastro L.K., de Anda J., Jain N., Grando K.C.M., Miller A.L., Bessho S., Gallucci S., Wong G.C.L., T\u00fckel \u00c7. Assembly of ordered DNA-curli fibril complexes during Salmonella biofilm formation correlates with strengths of the type I interferon and autoimmune responses. PLoS Pathog. 2022;18:e1010742. doi: 10.1371/journal.ppat.1010742.", "ArticleIdList": ["10.1371/journal.ppat.1010742", "PMC9380926", "35972973"]}, {"Citation": "T\u00fckel C., Raffatellu M., Humphries A.D., Wilson R.P., Andrews-Polymenis H.L., Gull T., Figueiredo J.F., Wong M.H., Michelsen K.S., Ak\u00e7elik M., et al. CsgA is a pathogen-associated molecular pattern of Salmonella enterica serotype Typhimurium that is recognized by Toll-like receptor 2. Mol. Microbiol. 2005;58:289\u2013304. doi: 10.1111/j.1365-2958.2005.04825.x.", "ArticleIdList": ["10.1111/j.1365-2958.2005.04825.x", "16164566"]}, {"Citation": "Bian Z., Brauner A., Li Y., Normark S. Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. J. Infect. Dis. 2000;181:602\u2013612. doi: 10.1086/315233.", "ArticleIdList": ["10.1086/315233", "10669344"]}, {"Citation": "Kai-Larsen Y., L\u00fcthje P., Chromek M., Peters V., Wang X., Holm A., K\u00e1das L., Hedlund K.O., Johansson J., Chapman M.R., et al. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog. 2010;6:e1001010. doi: 10.1371/journal.ppat.1001010.", "ArticleIdList": ["10.1371/journal.ppat.1001010", "PMC2908543", "20661475"]}, {"Citation": "Lane M.C., Lockatell V., Monterosso G., Lamphier D., Weinert J., Hebel J.R., Johnson D.E., Mobley H.L. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 2005;73:7644\u20137656. doi: 10.1128/IAI.73.11.7644-7656.2005.", "ArticleIdList": ["10.1128/IAI.73.11.7644-7656.2005", "PMC1273871", "16239569"]}, {"Citation": "Wright K.J., Seed P.C., Hultgren S.J. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect. Immun. 2005;73:7657\u20137668. doi: 10.1128/IAI.73.11.7657-7668.2005.", "ArticleIdList": ["10.1128/IAI.73.11.7657-7668.2005", "PMC1273872", "16239570"]}, {"Citation": "Simms A.N., Mobley H.L. PapX, a P fimbrial operon-encoded inhibitor of motility in uropathogenic Escherichia coli. Infect. Immun. 2008;76:4833\u20134841. doi: 10.1128/IAI.00630-08.", "ArticleIdList": ["10.1128/IAI.00630-08", "PMC2573324", "18710869"]}, {"Citation": "Gir\u00f3n J.A., Torres A.G., Freer E., Kaper J.B. The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol. Microbiol. 2002;44:361\u2013379. doi: 10.1046/j.1365-2958.2002.02899.x.", "ArticleIdList": ["10.1046/j.1365-2958.2002.02899.x", "11972776"]}, {"Citation": "Nakamura Y., Yamamoto N., Kino Y., Yamamoto N., Kamei S., Mori H., Kurokawa K., Nakashima N. Establishment of a multi-species biofilm model and metatranscriptomic analysis of biofilm and planktonic cell communities. Appl. Microbiol. Biotechnol. 2016;100:7263\u20137279. doi: 10.1007/s00253-016-7532-6.", "ArticleIdList": ["10.1007/s00253-016-7532-6", "27102130"]}, {"Citation": "Lane M.C., Alteri C.J., Smith S.N., Mobley H.L. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl. Acad. Sci. USA. 2007;104:16669\u201316674. doi: 10.1073/pnas.0607898104.", "ArticleIdList": ["10.1073/pnas.0607898104", "PMC2034267", "17925449"]}, {"Citation": "Rosen D.A., Pinkner J.S., Jones J.M., Walker J.N., Clegg S., Hultgren S.J. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect. Immun. 2008;76:3337\u20133345. doi: 10.1128/IAI.00090-08.", "ArticleIdList": ["10.1128/IAI.00090-08", "PMC2446714", "18411285"]}, {"Citation": "Uhl\u00e9n P., Laestadius A., Jahnukainen T., S\u00f6derblom T., B\u00e4ckhed F., Celsi G., Brismar H., Normark S., Aperia A., Richter-Dahlfors A. Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells. Nature. 2000;405:694\u2013697. doi: 10.1038/35015091.", "ArticleIdList": ["10.1038/35015091", "10864327"]}, {"Citation": "Nagamatsu K., Hannan T.J., Guest R.L., Kostakioti M., Hadjifrangiskou M., Binkley J., Dodson K., Raivio T.L., Hultgren S.J. Dysregulation of Escherichia coli \u03b1-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl. Acad. Sci. USA. 2015;112:E871\u2013E880. doi: 10.1073/pnas.1500374112.", "ArticleIdList": ["10.1073/pnas.1500374112", "PMC4345586", "25675528"]}, {"Citation": "Lemonnier M., Landraud L., Lemichez E. Rho GTPase-activating bacterial toxins: From bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol. Rev. 2007;31:515\u2013534. doi: 10.1111/j.1574-6976.2007.00078.x.", "ArticleIdList": ["10.1111/j.1574-6976.2007.00078.x", "17680807"]}, {"Citation": "Petracchini S., Hamaoui D., Doye A., Asnacios A., Fage F., Vitiello E., Balland M., Janel S., Lafont F., Gupta M., et al. Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division. Nat. Commun. 2022;13:6059. doi: 10.1038/s41467-022-33803-x.", "ArticleIdList": ["10.1038/s41467-022-33803-x", "PMC9561704", "36229487"]}, {"Citation": "Hofman P., Le Negrate G., Mograbi B., Hofman V., Brest P., Alliana-Schmid A., Flatau G., Boquet P., Rossi B. Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis. J. Leukoc. Biol. 2000;68:522\u2013528. doi: 10.1189/jlb.68.4.522.", "ArticleIdList": ["10.1189/jlb.68.4.522", "11037974"]}, {"Citation": "Pokharel P., Dhakal S., Dozois C.M. The Diversity of Escherichia coli Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen. Microorganisms. 2023;11:344. doi: 10.3390/microorganisms11020344.", "ArticleIdList": ["10.3390/microorganisms11020344", "PMC9965155", "36838308"]}, {"Citation": "Heimer S.R., Rasko D.A., Lockatell C.V., Johnson D.E., Mobley H.L. Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect. Immun. 2004;72:593\u2013597. doi: 10.1128/IAI.72.1.593-597.2004.", "ArticleIdList": ["10.1128/IAI.72.1.593-597.2004", "PMC343984", "14688142"]}, {"Citation": "Guyer D.M., Radulovic S., Jones F.E., Mobley H.L. Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect. Immun. 2002;70:4539\u20134546. doi: 10.1128/IAI.70.8.4539-4546.2002.", "ArticleIdList": ["10.1128/IAI.70.8.4539-4546.2002", "PMC128167", "12117966"]}, {"Citation": "Guyer D.M., Henderson I.R., Nataro J.P., Mobley H.L. Identification of sat, an autotransporter toxin produced by uropathogenic Escherichia coli. Mol. Microbiol. 2000;38:53\u201366. doi: 10.1046/j.1365-2958.2000.02110.x.", "ArticleIdList": ["10.1046/j.1365-2958.2000.02110.x", "11029690"]}, {"Citation": "Dutta P.R., Cappello R., Navarro-Garc\u00eda F., Nataro J.P. Functional comparison of serine protease autotransporters of enterobacteriaceae. Infect. Immun. 2002;70:7105\u20137113. doi: 10.1128/IAI.70.12.7105-7113.2002.", "ArticleIdList": ["10.1128/IAI.70.12.7105-7113.2002", "PMC133081", "12438392"]}, {"Citation": "Li\u00e9vin-Le Moal V., Comenge Y., Ruby V., Amsellem R., Nicolas V., Servin A.L. Secreted autotransporter toxin (Sat) triggers autophagy in epithelial cells that relies on cell detachment. Cell Microbiol. 2011;13:992\u20131013. doi: 10.1111/j.1462-5822.2011.01595.x.", "ArticleIdList": ["10.1111/j.1462-5822.2011.01595.x", "21501364"]}, {"Citation": "Parham N.J., Srinivasan U., Desvaux M., Foxman B., Marrs C.F., Henderson I.R. PicU, a second serine protease autotransporter of uropathogenic Escherichia coli. FEMS Microbiol. Lett. 2004;230:73\u201383. doi: 10.1016/S0378-1097(03)00862-0.", "ArticleIdList": ["10.1016/S0378-1097(03)00862-0", "14734168"]}, {"Citation": "Nichols K.B., Totsika M., Moriel D.G., Lo A.W., Yang J., Wurpel D.J., Rossiter A.E., Strugnell R.A., Henderson I.R., Ulett G.C., et al. Molecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli. J. Bacteriol. 2016;198:1487\u20131498. doi: 10.1128/JB.00791-15.", "ArticleIdList": ["10.1128/JB.00791-15", "PMC4859599", "26858103"]}, {"Citation": "D\u00edaz J.M., Dozois C.M., Avelar-Gonz\u00e1lez F.J., Hern\u00e1ndez-Cuellar E., Pokharel P., de Santiago A.S., Guerrero-Barrera A.L. The Vacuolating Autotransporter Toxin (Vat) of Escherichia coli Causes Cell Cytoskeleton Changes and Produces Non-lysosomal Vacuole Formation in Bladder Epithelial Cells. Front. Cell Infect. Microbiol. 2020;10:299. doi: 10.3389/fcimb.2020.00299.", "ArticleIdList": ["10.3389/fcimb.2020.00299", "PMC7332727", "32670893"]}, {"Citation": "Skaar E.P. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 2010;6:e1000949. doi: 10.1371/journal.ppat.1000949.", "ArticleIdList": ["10.1371/journal.ppat.1000949", "PMC2920840", "20711357"]}, {"Citation": "Valdebenito M., Bister B., Reissbrodt R., Hantke K., Winkelmann G. The detection of salmochelin and yersiniabactin in uropathogenic Escherichia coli strains by a novel hydrolysis-fluorescence-detection (HFD) method. Int. J. Med. Microbiol. 2005;295:99\u2013107. doi: 10.1016/j.ijmm.2005.02.001.", "ArticleIdList": ["10.1016/j.ijmm.2005.02.001", "15969470"]}, {"Citation": "Jones R.L., Peterson C.M., Grady R.W., Cerami A. Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth. J. Exp. Med. 1980;151:418\u2013428. doi: 10.1084/jem.151.2.418.", "ArticleIdList": ["10.1084/jem.151.2.418", "PMC2185783", "6985950"]}, {"Citation": "Porcheron G., Habib R., Houle S., Caza M., L\u00e9pine F., Daigle F., Mass\u00e9 E., Dozois C.M. The small RNA RyhB contributes to siderophore production and virulence of uropathogenic Escherichia coli. Infect. Immun. 2014;82:5056\u20135068. doi: 10.1128/IAI.02287-14.", "ArticleIdList": ["10.1128/IAI.02287-14", "PMC4249264", "25245805"]}, {"Citation": "Hagan E.C., Mobley H.L. Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol. Microbiol. 2009;71:79\u201391. doi: 10.1111/j.1365-2958.2008.06509.x.", "ArticleIdList": ["10.1111/j.1365-2958.2008.06509.x", "PMC2736550", "19019144"]}, {"Citation": "Stojiljkovic I., Perkins-Balding D. Processing of heme and heme-containing proteins by bacteria. DNA Cell Biol. 2002;21:281\u2013295. doi: 10.1089/104454902753759708.", "ArticleIdList": ["10.1089/104454902753759708", "12042068"]}, {"Citation": "Henderson J.P., Crowley J.R., Pinkner J.S., Walker J.N., Tsukayama P., Stamm W.E., Hooton T.M., Hultgren S.J. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog. 2009;5:e1000305. doi: 10.1371/journal.ppat.1000305.", "ArticleIdList": ["10.1371/journal.ppat.1000305", "PMC2637984", "19229321"]}, {"Citation": "Raffatellu M., George M.D., Akiyama Y., Hornsby M.J., Nuccio S.P., Paixao T.A., Butler B.P., Chu H., Santos R.L., Berger T., et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe. 2009;5:476\u2013486. doi: 10.1016/j.chom.2009.03.011.", "ArticleIdList": ["10.1016/j.chom.2009.03.011", "PMC2768556", "19454351"]}, {"Citation": "Valdebenito M., Crumbliss A.L., Winkelmann G., Hantke K. Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int. J. Med. Microbiol. 2006;296:513\u2013520. doi: 10.1016/j.ijmm.2006.06.003.", "ArticleIdList": ["10.1016/j.ijmm.2006.06.003", "17008127"]}, {"Citation": "Feldmann F., Sorsa L.J., Hildinger K., Schubert S. The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro. Infect. Immun. 2007;75:3183\u20133187. doi: 10.1128/IAI.00656-06.", "ArticleIdList": ["10.1128/IAI.00656-06", "PMC1932905", "17353289"]}, {"Citation": "Russo T.A., Mcfadden C.D., Carlino-Macdonald U.B., Beanan J.M., Olson R., Wilding G.E. The Siderophore Receptor IroN of Extraintestinal Pathogenic Escherichia coli Is a Potential Vaccine Candidate. Infect. Immun. 2003;71:7164\u20137169. doi: 10.1128/IAI.71.12.7164-7169.2003.", "ArticleIdList": ["10.1128/IAI.71.12.7164-7169.2003", "PMC308914", "14638809"]}, {"Citation": "Chaturvedi K.S., Hung C.S., Crowley J.R., Stapleton A.E., Henderson J.P. The siderophore yersiniabactin binds copper to protect pathogens during infection. Nat. Chem. Biol. 2012;8:731\u2013736. doi: 10.1038/nchembio.1020.", "ArticleIdList": ["10.1038/nchembio.1020", "PMC3600419", "22772152"]}, {"Citation": "Reigstad C.S., Hultgren S.J., Gordon J.I. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J. Biol. Chem. 2007;282:21259\u201321267. doi: 10.1074/jbc.M611502200.", "ArticleIdList": ["10.1074/jbc.M611502200", "17504765"]}, {"Citation": "Watts R.E., Totsika M., Challinor V.L., Mabbett A.N., Ulett G.C., De Voss J.J., Schembri M.A. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun. 2012;80:333\u2013344. doi: 10.1128/IAI.05594-11.", "ArticleIdList": ["10.1128/IAI.05594-11", "PMC3255690", "21930757"]}, {"Citation": "Garcia E.C., Brumbaugh A.R., Mobley H.L. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun. 2011;79:1225\u20131235. doi: 10.1128/IAI.01222-10.", "ArticleIdList": ["10.1128/IAI.01222-10", "PMC3067483", "21220482"]}, {"Citation": "Torres A.G., Redford P., Welch R.A., Payne S.M. TonB-dependent systems of uropathogenic Escherichia coli: Aerobactin and heme transport and TonB are required for virulence in the mouse. Infect. Immun. 2001;69:6179\u20136185. doi: 10.1128/IAI.69.10.6179-6185.2001.", "ArticleIdList": ["10.1128/IAI.69.10.6179-6185.2001", "PMC98749", "11553558"]}, {"Citation": "Justice S.S., Hung C., Theriot J.A., Fletcher D.A., Anderson G.G., Footer M.J., Hultgren S.J. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA. 2004;101:1333\u20131338. doi: 10.1073/pnas.0308125100.", "ArticleIdList": ["10.1073/pnas.0308125100", "PMC337053", "14739341"]}, {"Citation": "Rosen D.A., Hooton T.M., Stamm W.E., Humphrey P.A., Hultgren S.J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 2007;4:e329. doi: 10.1371/journal.pmed.0040329.", "ArticleIdList": ["10.1371/journal.pmed.0040329", "PMC2140087", "18092884"]}, {"Citation": "Anderson G.G., Martin S.M., Hultgren S.J. Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes Infect. 2004;6:1094\u20131101. doi: 10.1016/j.micinf.2004.05.023.", "ArticleIdList": ["10.1016/j.micinf.2004.05.023", "15380779"]}, {"Citation": "Eto D.S., Sundsbak J.L., Mulvey M.A. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol. 2006;8:704\u2013717. doi: 10.1111/j.1462-5822.2006.00691.x.", "ArticleIdList": ["10.1111/j.1462-5822.2006.00691.x", "16548895"]}, {"Citation": "Leatham-Jensen M.P., Mokszycki M.E., Rowley D.C., Deering R., Camberg J.L., Sokurenko E.V., Tchesnokova V.L., Frimodt-M\u00f8ller J., Krogfelt K.A., Leth Nielsen K., et al. Uropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract Infection. mSphere. 2016;1:e00055-15. doi: 10.1128/mSphere.00055-15.", "ArticleIdList": ["10.1128/mSphere.00055-15", "PMC4863606", "27303698"]}, {"Citation": "Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell. 2002;10:1033\u20131043. doi: 10.1016/S1097-2765(02)00708-6.", "ArticleIdList": ["10.1016/S1097-2765(02)00708-6", "12453412"]}, {"Citation": "Fischbach M.A., Lin H., Zhou L., Yu Y., Abergel R.J., Liu D.R., Raymond K.N., Wanner B.L., Strong R.K., Walsh C.T., et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc. Natl. Acad. Sci. USA. 2006;103:16502\u201316507. doi: 10.1073/pnas.0604636103.", "ArticleIdList": ["10.1073/pnas.0604636103", "PMC1637611", "17060628"]}, {"Citation": "Smith K.D. Iron metabolism at the host pathogen interface: Lipocalin 2 and the pathogen-associated iroA gene cluster. Int. J. Biochem. Cell Biol. 2007;39:1776\u20131780. doi: 10.1016/j.biocel.2007.07.003.", "ArticleIdList": ["10.1016/j.biocel.2007.07.003", "PMC2695446", "17714976"]}, {"Citation": "Simpson B.W., May J.M., Sherman D.J., Kahne D., Ruiz N. Lipopolysaccharide transport to the cell surface: Biosynthesis and extraction from the inner membrane. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2015;370:20150029. doi: 10.1098/rstb.2015.0029.", "ArticleIdList": ["10.1098/rstb.2015.0029", "PMC4632605", "26370941"]}, {"Citation": "Maldonado R.F., S\u00e1-Correia I., Valvano M.A. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol. Rev. 2016;40:480\u2013493. doi: 10.1093/femsre/fuw007.", "ArticleIdList": ["10.1093/femsre/fuw007", "PMC4931227", "27075488"]}, {"Citation": "Billips B.K., Schaeffer A.J., Klumpp D.J. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect. Immun. 2008;76:3891\u20133900. doi: 10.1128/IAI.00069-08.", "ArticleIdList": ["10.1128/IAI.00069-08", "PMC2519411", "18559433"]}, {"Citation": "Hunstad D.A., Justice S.S., Hung C.S., Lauer S.R., Hultgren S.J. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect. Immun. 2005;73:3999\u20134006. doi: 10.1128/IAI.73.7.3999-4006.2005.", "ArticleIdList": ["10.1128/IAI.73.7.3999-4006.2005", "PMC1168571", "15972487"]}, {"Citation": "Jacobson S.H., Ostenson C.G., Tullus K., Brauner A. Serum resistance in Escherichia coli strains causing acute pyelonephritis and bacteraemia. Apmis. 1992;100:147\u2013153. doi: 10.1111/j.1699-0463.1992.tb00854.x.", "ArticleIdList": ["10.1111/j.1699-0463.1992.tb00854.x", "1554489"]}, {"Citation": "Fux C.A., Costerton J.W., Stewart P.S., Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol. 2005;13:34\u201340. doi: 10.1016/j.tim.2004.11.010.", "ArticleIdList": ["10.1016/j.tim.2004.11.010", "15639630"]}, {"Citation": "Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284:1318\u20131322. doi: 10.1126/science.284.5418.1318.", "ArticleIdList": ["10.1126/science.284.5418.1318", "10334980"]}, {"Citation": "Ejrn\u00e6s K., Stegger M., Reisner A., Ferry S., Monsen T., Holm S.E., Lundgren B., Frimodt-M\u00f8ller N. Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: Phylogenetic groups, virulence factors and biofilm formation. Virulence. 2011;2:528\u2013537. doi: 10.4161/viru.2.6.18189.", "ArticleIdList": ["10.4161/viru.2.6.18189", "22030858"]}, {"Citation": "Norinder B.S., L\u00fcthje P., Yadav M., Kadas L., Fang H., Nord C.E., Brauner A. Cellulose and PapG are important for Escherichia coli causing recurrent urinary tract infection in women. Infection. 2011;39:571\u2013574. doi: 10.1007/s15010-011-0199-0.", "ArticleIdList": ["10.1007/s15010-011-0199-0", "22002732"]}, {"Citation": "Salo J., Sevander J.J., Tapiainen T., Ik\u00e4heimo I., Pokka T., Koskela M., Uhari M. Biofilm formation by Escherichia coli isolated from patients with urinary tract infections. Clin. Nephrol. 2009;71:501\u2013507. doi: 10.5414/CNP71501.", "ArticleIdList": ["10.5414/CNP71501", "19473609"]}, {"Citation": "Tapiainen T., Hanni A.M., Salo J., Ik\u00e4heimo I., Uhari M. Escherichia coli biofilm formation and recurrences of urinary tract infections in children. Eur. J. Clin. Microbiol. Infect. Dis. 2014;33:111\u2013115. doi: 10.1007/s10096-013-1935-4.", "ArticleIdList": ["10.1007/s10096-013-1935-4", "23996047"]}, {"Citation": "Bahrani-Mougeot F.K., Buckles E.L., Lockatell C.V., Hebel J.R., Johnson D.E., Tang C.M., Donnenberg M.S. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol. 2002;45:1079\u20131093. doi: 10.1046/j.1365-2958.2002.03078.x.", "ArticleIdList": ["10.1046/j.1365-2958.2002.03078.x", "12180926"]}, {"Citation": "Subashchandrabose S., Smith S.N., Spurbeck R.R., Kole M.M., Mobley H.L. Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog. 2013;9:e1003788. doi: 10.1371/journal.ppat.1003788.", "ArticleIdList": ["10.1371/journal.ppat.1003788", "PMC3855560", "24339777"]}, {"Citation": "Conway C., Beckett M.C., Dorman C.J. The DNA relaxation-dependent OFF-to-ON biasing of the type 1 fimbrial genetic switch requires the Fis nucleoid-associated protein. Microbiology. 2023;169:001283. doi: 10.1099/mic.0.001283.", "ArticleIdList": ["10.1099/mic.0.001283", "PMC9993118", "36748578"]}, {"Citation": "Bryan A., Roesch P., Davis L., Moritz R., Pellett S., Welch R.A. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Infect. Immun. 2006;74:1072\u20131083. doi: 10.1128/IAI.74.2.1072-1083.2006.", "ArticleIdList": ["10.1128/IAI.74.2.1072-1083.2006", "PMC1360361", "16428754"]}, {"Citation": "Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 2010;7:653\u2013660. doi: 10.1038/nrurol.2010.190.", "ArticleIdList": ["10.1038/nrurol.2010.190", "21139641"]}, {"Citation": "Gupta K., Grigoryan L., Trautner B. Urinary Tract Infection. Ann. Intern. Med. 2017;167:Itc49\u2013Itc64. doi: 10.7326/AITC201710030.", "ArticleIdList": ["10.7326/AITC201710030", "28973215"]}, {"Citation": "Chu C.M., Lowder J.L. Diagnosis and treatment of urinary tract infections across age groups. Am. J. Obstet. Gynecol. 2018;219:40\u201351. doi: 10.1016/j.ajog.2017.12.231.", "ArticleIdList": ["10.1016/j.ajog.2017.12.231", "29305250"]}, {"Citation": "Muller A.E., Verhaegh E.M., Harbarth S., Mouton J.W., Huttner A. Nitrofurantoin\u2019s efficacy and safety as prophylaxis for urinary tract infections: A systematic review of the literature and meta-analysis of controlled trials. Clin. Microbiol. Infect. 2017;23:355\u2013362. doi: 10.1016/j.cmi.2016.08.003.", "ArticleIdList": ["10.1016/j.cmi.2016.08.003", "27542332"]}, {"Citation": "Davis W.H., Magee M.R., Monks S.M., Geno K.A., Crawford S.B. Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments. Am. J. Emerg. Med. 2022;61:12\u201317. doi: 10.1016/j.ajem.2022.08.023.", "ArticleIdList": ["10.1016/j.ajem.2022.08.023", "36027632"]}, {"Citation": "Gupta K., Hooton T.M., Roberts P.L., Stamm W.E. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch. Intern. Med. 2007;167:2207\u20132212. doi: 10.1001/archinte.167.20.2207.", "ArticleIdList": ["10.1001/archinte.167.20.2207", "17998493"]}, {"Citation": "Moya-Dionisio V., D\u00edaz-Zabala M., Ib\u00e1\u00f1ez-Fern\u00e1ndez A., Su\u00e1rez-Leiva P., Mart\u00ednez-Su\u00e1rez V., Ord\u00f3\u00f1ez-\u00c1lvarez F.A., Santos-Rodr\u00edguez F. Uropathogen pattern and antimicrobial susceptibility in positive urinary cultures isolates from paediatric patients. Rev. Esp. Quimioter. 2016;29:146\u2013150.", "ArticleIdList": ["27092771"]}, {"Citation": "Nicolle L.E. Pivmecillinam in the treatment of urinary tract infections. J. Antimicrob. Chemother. 2000;46:35\u201339; discussion 63\u201365. doi: 10.1093/jac/46.suppl_1.35.", "ArticleIdList": ["10.1093/jac/46.suppl_1.35", "11051622"]}, {"Citation": "Bader M.S., Loeb M., Leto D., Brooks A.A. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad. Med. 2020;132:234\u2013250. doi: 10.1080/00325481.2019.1680052.", "ArticleIdList": ["10.1080/00325481.2019.1680052", "31608743"]}, {"Citation": "Quek W.M., Teng C.B., Tan Y.Z., Chong K., Lye D.C., Ng T.M. Outcomes of Fosfomycin Use in Ceftriaxone-Resistant Enterobacteriaceae Urinary Tract Infection in the Elderly. Int. J. Antimicrob. Agents. 2019;53:195\u2013196. doi: 10.1016/j.ijantimicag.2018.10.008.", "ArticleIdList": ["10.1016/j.ijantimicag.2018.10.008", "30722963"]}, {"Citation": "Peretz A., Naamneh B., Tkhawkho L., Nitzan O. High Rates of Fosfomycin Resistance in Gram-Negative Urinary Isolates from Israel. Microb. Drug. Resist. 2019;25:408\u2013412. doi: 10.1089/mdr.2018.0393.", "ArticleIdList": ["10.1089/mdr.2018.0393", "30724694"]}, {"Citation": "Gupta K., Hooton T.M., Naber K.G., Wullt B., Colgan R., Miller L.G., Moran G.J., Nicolle L.E., Raz R., Schaeffer A.J., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 2011;52:e103\u2013e120. doi: 10.1093/cid/ciq257.", "ArticleIdList": ["10.1093/cid/ciq257", "21292654"]}, {"Citation": "Chen Y.H., Ko W.C., Hsueh P.R. Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections. Expert Opin. Pharm. 2013;14:587\u2013596. doi: 10.1517/14656566.2013.778827.", "ArticleIdList": ["10.1517/14656566.2013.778827", "23480061"]}, {"Citation": "Paterson D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Med. 2006;34:S20\u2013S28; discussion S62\u2013S70. doi: 10.1016/j.amjmed.2006.03.013.", "ArticleIdList": ["10.1016/j.amjmed.2006.03.013", "16735147"]}, {"Citation": "Pendleton J.N., Gorman S.P., Gilmore B.F. Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti. Infect. Ther. 2013;11:297\u2013308. doi: 10.1586/eri.13.12.", "ArticleIdList": ["10.1586/eri.13.12", "23458769"]}, {"Citation": "Gupta K., Bhadelia N. Management of urinary tract infections from multidrug-resistant organisms. Infect. Dis. Clin. N. Am. 2014;28:49\u201359. doi: 10.1016/j.idc.2013.10.002.", "ArticleIdList": ["10.1016/j.idc.2013.10.002", "24484574"]}, {"Citation": "Bader M.S., Loeb M., Brooks A.A. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad. Med. 2017;129:242\u2013258. doi: 10.1080/00325481.2017.1246055.", "ArticleIdList": ["10.1080/00325481.2017.1246055", "27712137"]}, {"Citation": "Garau J. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: Fosfomycin, nitrofurantoin and tigecycline. Clin. Microbiol. Infect. 2008;14:198\u2013202. doi: 10.1111/j.1469-0691.2007.01852.x.", "ArticleIdList": ["10.1111/j.1469-0691.2007.01852.x", "18154548"]}, {"Citation": "Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: A clinical update. Clin. Microbiol. Rev. 2005;18:657\u2013686. doi: 10.1128/CMR.18.4.657-686.2005.", "ArticleIdList": ["10.1128/CMR.18.4.657-686.2005", "PMC1265908", "16223952"]}, {"Citation": "Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 2001;14:933\u2013951. doi: 10.1128/CMR.14.4.933-951.2001.", "ArticleIdList": ["10.1128/CMR.14.4.933-951.2001", "PMC89009", "11585791"]}, {"Citation": "Chang U.I., Kim H.W., Wie S.H. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. Korean J. Intern. Med. 2016;31:145\u2013155. doi: 10.3904/kjim.2016.31.1.145.", "ArticleIdList": ["10.3904/kjim.2016.31.1.145", "PMC4712418", "26767868"]}, {"Citation": "Whelan S., O\u2019Grady M.C., Corcoran G.D., Finn K., Lucey B. Effect of Sub-Inhibitory Concentrations of Nitrofurantoin, Ciprofloxacin, and Trimethoprim on In Vitro Biofilm Formation in Uropathogenic Escherichia coli (UPEC) Med. Sci. 2022;11:1. doi: 10.3390/medsci11010001.", "ArticleIdList": ["10.3390/medsci11010001", "PMC9844298", "36649038"]}, {"Citation": "Walker G.K., Suyemoto M.M., Hull D.M., Gall S., Jimenez F., Chen L.R., Thakur S., Crespo R., Borst L.B. Genomic Characterization of a Nalidixic Acid-Resistant Salmonella Enteritidis Strain Causing Persistent Infections in Broiler Chickens. Front. Vet. Sci. 2021;8:725737. doi: 10.3389/fvets.2021.725737.", "ArticleIdList": ["10.3389/fvets.2021.725737", "PMC8440904", "34540936"]}, {"Citation": "Khan A., Jabeen H., Ahmad T., Rehman N.U., Khan S.S., Shareef H., Sarwar R., Yahya S., Hussain N., Uddin J., et al. Comparative efficacy of cephradine-loaded silver and gold nanoparticles against resistant human pathogens. Artif. Cells Nanomed. Biotechnol. 2022;50:312\u2013321. doi: 10.1080/21691401.2022.2144340.", "ArticleIdList": ["10.1080/21691401.2022.2144340", "36380462"]}, {"Citation": "Millner R., Becknell B. Urinary Tract Infections. Pediatr. Clin. N. Am. 2019;66:1\u201313. doi: 10.1016/j.pcl.2018.08.002.", "ArticleIdList": ["10.1016/j.pcl.2018.08.002", "30454735"]}, {"Citation": "Zalewska-Pi\u0105tek B.M., Pi\u0105tek R.J. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains. Acta Biochim. Pol. 2019;66:129\u2013138. doi: 10.18388/abp.2018_2787.", "ArticleIdList": ["10.18388/abp.2018_2787", "31136644"]}, {"Citation": "Saatchi A., Yoo J.W., Schwartz K.L., Silverman M., Morris A.M., Patrick D.M., McCormack J., Marra F. Quantifying the Gap between Expected and Actual Rates of Antibiotic Prescribing in British Columbia, Canada. Antibiotics. 2021;10:1428. doi: 10.3390/antibiotics10111428.", "ArticleIdList": ["10.3390/antibiotics10111428", "PMC8615253", "34827366"]}, {"Citation": "McLellan L.K., Hunstad D.A. Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol. Med. 2016;22:946\u2013957. doi: 10.1016/j.molmed.2016.09.003.", "ArticleIdList": ["10.1016/j.molmed.2016.09.003", "PMC5159206", "27692880"]}, {"Citation": "Grischke E.M., R\u00fcttgers H. Treatment of bacterial infections of the female urinary tract by immunization of the patients. Urol. Int. 1987;42:338\u2013341. doi: 10.1159/000281988.", "ArticleIdList": ["10.1159/000281988", "3324441"]}, {"Citation": "Hopkins W.J., Elkahwaji J., Beierle L.M., Leverson G.E., Uehling D.T. Vaginal mucosal vaccine for recurrent urinary tract infections in women: Results of a phase 2 clinical trial. J. Urol. 2007;177:1349\u20131353. doi: 10.1016/j.juro.2006.11.093.", "ArticleIdList": ["10.1016/j.juro.2006.11.093", "17382730"]}, {"Citation": "Beerepoot M.A., Geerlings S.E., van Haarst E.P., van Charante N.M., ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: A systematic review and meta-analysis of randomized controlled trials. J. Urol. 2013;190:1981\u20131989. doi: 10.1016/j.juro.2013.04.142.", "ArticleIdList": ["10.1016/j.juro.2013.04.142", "23867306"]}, {"Citation": "Kochiashvili D., Khuskivadze A., Kochiashvili G., Koberidze G., Kvakhajelidze V. Role of the bacterial vaccine Solco-Urovac\u00ae in treatment and prevention of recurrent urinary tract infections of bacterial origin. Georgian. Med. News. 2014;231:11\u201316.", "ArticleIdList": ["25020163"]}, {"Citation": "Wade D., Cooper J., Derry F., Taylor J. Uro-Vaxom\u00ae versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: A randomised controlled feasibility study. Trials. 2019;20:223. doi: 10.1186/s13063-019-3275-x.", "ArticleIdList": ["10.1186/s13063-019-3275-x", "PMC6469220", "30992071"]}, {"Citation": "Magasi P., P\u00e1novics J., Ill\u00e9s A., Nagy M. Uro-Vaxom and the management of recurrent urinary tract infection in adults: A randomized multicenter double-blind trial. Eur. Urol. 1994;26:137\u2013140. doi: 10.1159/000475363.", "ArticleIdList": ["10.1159/000475363", "7957468"]}, {"Citation": "Cruz F., Dambros M., Naber K.G., Bauer H.W., Cozma G. Recurrent Urinary Tract Infections: Uro-Vaxom, a New Alternative. Eur. Urol. Suppl. 2009;8:762\u2013768. doi: 10.1016/j.eursup.2009.07.002.", "ArticleIdList": ["10.1016/j.eursup.2009.07.002"]}, {"Citation": "Kim K.S., Kim J.Y., Jeong I.G., Paick J.S., Son H., Lim D.J., Shim H.B., Park W.H., Jung H.C., Choo M.S. A prospective multi-center trial of Escherichia coli extract for the prophylactic treatment of patients with chronically recurrent cystitis. J. Korean Med. Sci. 2010;25:435\u2013439. doi: 10.3346/jkms.2010.25.3.435.", "ArticleIdList": ["10.3346/jkms.2010.25.3.435", "PMC2826739", "20191044"]}, {"Citation": "Magistro G., Stief C.G. Vaccine Development for Urinary Tract Infections: Where Do We Stand? Eur. Urol. Focus. 2019;5:39\u201341. doi: 10.1016/j.euf.2018.07.034.", "ArticleIdList": ["10.1016/j.euf.2018.07.034", "30093359"]}, {"Citation": "Marinova S., Nenkov P., Markova R., Nikolaeva S., Kostadinova R., Mitov I., Vretenarska M. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int. J. Immunopathol. Pharmacol. 2005;18:457\u2013473. doi: 10.1177/039463200501800306.", "ArticleIdList": ["10.1177/039463200501800306", "16164822"]}, {"Citation": "Del Bino L., \u00d8sterlid K.E., Wu D.Y., Nonne F., Romano M.R., Cod\u00e9e J., Adamo R. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance. Chem. Rev. 2022;122:15672\u201315716. doi: 10.1021/acs.chemrev.2c00021.", "ArticleIdList": ["10.1021/acs.chemrev.2c00021", "PMC9614730", "35608633"]}, {"Citation": "Russo T.A., Beanan J.M., Olson R., MacDonald U., Cope J.J. Capsular polysaccharide and the O-specific antigen impede antibody binding: A potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine. Vaccine. 2009;27:388\u2013395. doi: 10.1016/j.vaccine.2008.10.082.", "ArticleIdList": ["10.1016/j.vaccine.2008.10.082", "19014988"]}, {"Citation": "Billips B.K., Yaggie R.E., Cashy J.P., Schaeffer A.J., Klumpp D.J. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J. Infect. Dis. 2009;200:263\u2013272. doi: 10.1086/599839.", "ArticleIdList": ["10.1086/599839", "19522648"]}, {"Citation": "Horvath D.J., Jr., Patel A.S., Mohamed A., Storm D.W., Singh C., Li B., Zhang J., Koff S.A., Jayanthi V.R., Mason K.M., et al. Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract. J. Bacteriol. 2016;198:964\u2013972. doi: 10.1128/JB.00664-15.", "ArticleIdList": ["10.1128/JB.00664-15", "PMC4772593", "26755631"]}, {"Citation": "Uehling D.T., Hopkins W.J., Dahmer L.A., Balish E. Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection. J. Urol. 1994;152:2308\u20132311. doi: 10.1016/S0022-5347(17)31664-6.", "ArticleIdList": ["10.1016/S0022-5347(17)31664-6", "7966729"]}, {"Citation": "Uehling D.T., Hopkins W.J., Elkahwaji J.E., Schmidt D.M., Leverson G.E. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J. Urol. 2003;170:867\u2013869. doi: 10.1097/01.ju.0000075094.54767.6e.", "ArticleIdList": ["10.1097/01.ju.0000075094.54767.6e", "12913718"]}, {"Citation": "Russo T.A., Beanan J.M., Olson R., Genagon S.A., MacDonald U., Cope J.J., Davidson B.A., Johnston B., Johnson J.R. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine. 2007;25:3859\u20133870. doi: 10.1016/j.vaccine.2007.01.100.", "ArticleIdList": ["10.1016/j.vaccine.2007.01.100", "PMC1913199", "17306426"]}, {"Citation": "Billips B.K., Forrestal S.G., Rycyk M.T., Johnson J.R., Klumpp D.J., Schaeffer A.J. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun. 2007;75:5353\u20135360. doi: 10.1128/IAI.00922-07.", "ArticleIdList": ["10.1128/IAI.00922-07", "PMC2168307", "17724068"]}, {"Citation": "William B.S., Darren A., Bart S., Oscar G., Wouter H., Tiziano D.R., Kellen F., Jan P., Stefan T., Ibarra D. 2712. Safety and Immunogenicity of two Doses of ExPEC4V Vaccine Against Extraintestinal Pathogenic Escherichia coli Disease in Healthy Adult Participants. Open Forum Infect. Dis. 2019;6:S954."}, {"Citation": "Frenck R.W., Jr., Ervin J., Chu L., Abbanat D., Spiessens B., Go O., Haazen W., van den Dobbelsteen G., Poolman J., Thoelen S., et al. Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): A phase 2 randomised controlled trial. Lancet Infect. Dis. 2019;19:631\u2013640. doi: 10.1016/S1473-3099(18)30803-X.", "ArticleIdList": ["10.1016/S1473-3099(18)30803-X", "31079947"]}, {"Citation": "Asadi Karam M.R., Oloomi M., Mahdavi M., Habibi M., Bouzari S. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine. 2013;31:1210\u20131216. doi: 10.1016/j.vaccine.2012.12.059.", "ArticleIdList": ["10.1016/j.vaccine.2012.12.059", "23306365"]}, {"Citation": "Hasanzadeh S., Habibi M., Shokrgozar M.A., Ahangari Cohan R., Ahmadi K., Asadi Karam M.R., Bouzari S. In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli. Sci. Rep. 2020;10:16258. doi: 10.1038/s41598-020-73179-w.", "ArticleIdList": ["10.1038/s41598-020-73179-w", "PMC7530722", "33004862"]}, {"Citation": "Asadi Karam M.R., Habibi M., Bouzari S. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Mol. Immunol. 2019;108:56\u201367. doi: 10.1016/j.molimm.2019.02.007.", "ArticleIdList": ["10.1016/j.molimm.2019.02.007", "30784763"]}, {"Citation": "Savar N.S., Jahanian-Najafabadi A., Mahdavi M., Shokrgozar M.A., Jafari A., Bouzari S. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections. J. Biotechnol. 2014;175:31\u201337. doi: 10.1016/j.jbiotec.2014.01.037.", "ArticleIdList": ["10.1016/j.jbiotec.2014.01.037", "24530504"]}, {"Citation": "Asadi Karam M.R., Habibi M., Bouzari S. Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens. Biologicals. 2016;44:378\u2013386. doi: 10.1016/j.biologicals.2016.06.006.", "ArticleIdList": ["10.1016/j.biologicals.2016.06.006", "27461240"]}, {"Citation": "Habibi M., Asadi Karam M.R., Bouzari S. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection. Microb. Pathog. 2017;110:477\u2013483. doi: 10.1016/j.micpath.2017.07.037.", "ArticleIdList": ["10.1016/j.micpath.2017.07.037", "28754265"]}, {"Citation": "Brumbaugh A.R., Smith S.N., Mobley H.L. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect. Immun. 2013;81:3309\u20133316. doi: 10.1128/IAI.00470-13.", "ArticleIdList": ["10.1128/IAI.00470-13", "PMC3754202", "23798537"]}, {"Citation": "Huttner A., Hatz C., van den Dobbelsteen G., Abbanat D., Hornacek A., Fr\u00f6lich R., Dreyer A.M., Martin P., Davies T., Fae K., et al. Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: A randomised, single-blind, placebo-controlled phase 1b trial. Lancet Infect. Dis. 2017;17:528\u2013537. doi: 10.1016/S1473-3099(17)30108-1.", "ArticleIdList": ["10.1016/S1473-3099(17)30108-1", "28238601"]}, {"Citation": "Langermann S., Palaszynski S., Barnhart M., Auguste G., Pinkner J.S., Burlein J., Barren P., Koenig S., Leath S., Jones C.H., et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science. 1997;276:607\u2013611. doi: 10.1126/science.276.5312.607.", "ArticleIdList": ["10.1126/science.276.5312.607", "9110982"]}, {"Citation": "Poggio T.V., La Torre J.L., Scodeller E.A. Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge. Can. J. Microbiol. 2006;52:1093\u20131102. doi: 10.1139/w06-065.", "ArticleIdList": ["10.1139/w06-065", "17215901"]}, {"Citation": "Karam M.R., Oloomi M., Mahdavi M., Habibi M., Bouzari S. Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli. Mol. Immunol. 2013;54:32\u201339. doi: 10.1016/j.molimm.2012.11.002.", "ArticleIdList": ["10.1016/j.molimm.2012.11.002", "23220068"]}, {"Citation": "Bagherpour G., Fooladi A.A., Mehrabadi J.F., Nourani M.R., Einollahi B. Evaluation of mammalian codon usage of fimH in DNA vaccine design. Acta Microbiol. Immunol. Hung. 2011;58:259\u2013271. doi: 10.1556/amicr.58.2011.4.2.", "ArticleIdList": ["10.1556/amicr.58.2011.4.2", "22207284"]}, {"Citation": "Ferraro B., Morrow M.P., Hutnick N.A., Shin T.H., Lucke C.E., Weiner D.B. Clinical applications of DNA vaccines: Current progress. Clin. Infect. Dis. 2011;53:296\u2013302. doi: 10.1093/cid/cir334.", "ArticleIdList": ["10.1093/cid/cir334", "PMC3202319", "21765081"]}, {"Citation": "Imani Fooladi A.A., Bagherpour G., Khoramabadi N., Fallah Mehrabadi J., Mahdavi M., Halabian R., Amin M., Izadi Mobarakeh J., Einollahi B. Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccine. Clin. Exp. Vaccine Res. 2014;3:185\u2013193. doi: 10.7774/cevr.2014.3.2.185.", "ArticleIdList": ["10.7774/cevr.2014.3.2.185", "PMC4083071", "25003092"]}, {"Citation": "Roberts J.A., Kaack M.B., Baskin G., Chapman M.R., Hunstad D.A., Pinkner J.S., Hultgren S.J. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J. Urol. 2004;171:1682\u20131685. doi: 10.1097/01.ju.0000116123.05160.43.", "ArticleIdList": ["10.1097/01.ju.0000116123.05160.43", "PMC2838480", "15017266"]}, {"Citation": "Mike L.A., Smith S.N., Sumner C.A., Eaton K.A., Mobley H.L. Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection. Proc. Natl. Acad. Sci. USA. 2016;113:13468\u201313473. doi: 10.1073/pnas.1606324113.", "ArticleIdList": ["10.1073/pnas.1606324113", "PMC5127358", "27821778"]}, {"Citation": "Wieser A., Romann E., Magistro G., Hoffmann C., N\u00f6renberg D., Weinert K., Schubert S. A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infect. Immun. 2010;78:3432\u20133442. doi: 10.1128/IAI.00174-10.", "ArticleIdList": ["10.1128/IAI.00174-10", "PMC2916271", "20498257"]}, {"Citation": "Wieser A., Magistro G., N\u00f6renberg D., Hoffmann C., Schubert S. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS) Int. J. Med. Microbiol. 2012;302:10\u201318. doi: 10.1016/j.ijmm.2011.09.012.", "ArticleIdList": ["10.1016/j.ijmm.2011.09.012", "22000741"]}, {"Citation": "Alteri C.J., Hagan E.C., Sivick K.E., Smith S.N., Mobley H.L. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 2009;5:e1000586. doi: 10.1371/journal.ppat.1000586.", "ArticleIdList": ["10.1371/journal.ppat.1000586", "PMC2736566", "19806177"]}, {"Citation": "Cole S.T. Who will develop new antibacterial agents? Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014;369:20130430. doi: 10.1098/rstb.2013.0430.", "ArticleIdList": ["10.1098/rstb.2013.0430", "PMC4024223", "24821916"]}, {"Citation": "Marouf R.S., Mbarga J.A.M., Ermolaev A.V., Podoprigora I.V., Smirnova I.P., Yashina N.V., Zhigunova A.V., Martynenkova A.V. Antibacterial Activity of Medicinal Plants against Uropathogenic Escherichia coli. J. Pharm. Bioallied. Sci. 2022;14:1\u201312. doi: 10.4103/jpbs.jpbs_124_21.", "ArticleIdList": ["10.4103/jpbs.jpbs_124_21", "PMC9245916", "35784103"]}, {"Citation": "Shaheen G., Akram M., Jabeen F., Ali Shah S.M., Munir N., Daniyal M., Riaz M., Tahir I.M., Ghauri A.O., Sultana S., et al. Therapeutic potential of medicinal plants for the management of urinary tract infection: A systematic review. Clin. Exp. Pharmacol. Physiol. 2019;46:613\u2013624. doi: 10.1111/1440-1681.13092.", "ArticleIdList": ["10.1111/1440-1681.13092", "30932202"]}, {"Citation": "\u00c1lvarez-Mart\u00ednez F.J., Barraj\u00f3n-Catal\u00e1n E., Encinar J.A., Rodr\u00edguez-D\u00edaz J.C., Micol V. Antimicrobial Capacity of Plant Polyphenols against Gram-positive Bacteria: A Comprehensive Review. Curr. Med. Chem. 2020;27:2576\u20132606. doi: 10.2174/0929867325666181008115650.", "ArticleIdList": ["10.2174/0929867325666181008115650", "30295182"]}, {"Citation": "\u00c1lvarez-Mart\u00ednez F.J., Rodr\u00edguez J.C., Borr\u00e1s-Rocher F., Barraj\u00f3n-Catal\u00e1n E., Micol V. The antimicrobial capacity of Cistus salviifolius and Punica granatum plant extracts against clinical pathogens is related to their polyphenolic composition. Sci. Rep. 2021;11:588. doi: 10.1038/s41598-020-80003-y.", "ArticleIdList": ["10.1038/s41598-020-80003-y", "PMC7803989", "33436818"]}, {"Citation": "Upadhyay A., Upadhyaya I., Kollanoor-Johny A., Venkitanarayanan K. Combating pathogenic microorganisms using plant-derived antimicrobials: A minireview of the mechanistic basis. Biomed. Res. Int. 2014;2014:761741. doi: 10.1155/2014/761741.", "ArticleIdList": ["10.1155/2014/761741", "PMC4178913", "25298964"]}, {"Citation": "Khameneh B., Iranshahy M., Soheili V., Fazly Bazzaz B.S. Review on plant antimicrobials: A mechanistic viewpoint. Antimicrob. Resist. Infect. Control. 2019;8:118. doi: 10.1186/s13756-019-0559-6.", "ArticleIdList": ["10.1186/s13756-019-0559-6", "PMC6636059", "31346459"]}, {"Citation": "Deipenbrock M., Hensel A. Polymethoxylated flavones from Orthosiphon stamineus leaves as antiadhesive compounds against uropathogenic E. coli. Fitoterapia. 2019;139:104387. doi: 10.1016/j.fitote.2019.104387.", "ArticleIdList": ["10.1016/j.fitote.2019.104387", "31678632"]}, {"Citation": "Sarshar S., Sendker J., Qin X., Goycoolea F.M., Asadi Karam M.R., Habibi M., Bouzari S., Dobrindt U., Hensel A. Antiadhesive hydroalcoholic extract from Apium graveolens fruits prevents bladder and kidney infection against uropathogenic E. coli. Fitoterapia. 2018;127:237\u2013244. doi: 10.1016/j.fitote.2018.02.029.", "ArticleIdList": ["10.1016/j.fitote.2018.02.029", "29496563"]}, {"Citation": "Scharf B., Sendker J., Dobrindt U., Hensel A. Influence of Cranberry Extract on Tamm-Horsfall Protein in Human Urine and its Antiadhesive Activity Against Uropathogenic Escherichia coli. Planta Med. 2019;85:126\u2013138. doi: 10.1055/a-0755-7801.", "ArticleIdList": ["10.1055/a-0755-7801", "30312973"]}, {"Citation": "Mutters N.T., Mampel A., Kropidlowski R., Biehler K., G\u00fcnther F., B\u0103lu I., Malek V., Frank U. Treating urinary tract infections due to MDR E. coli with Isothiocyanates\u2014A phytotherapeutic alternative to antibiotics? Fitoterapia. 2018;129:237\u2013240. doi: 10.1016/j.fitote.2018.07.012.", "ArticleIdList": ["10.1016/j.fitote.2018.07.012", "30031115"]}, {"Citation": "Sabadash M., Shulyak A. Canephron\u00ae N in the treatment of recurrent cystitis in women of child-bearing Age: A randomised controlled study. Clin. Phyt. 2017;3:9. doi: 10.1186/s40816-017-0046-7.", "ArticleIdList": ["10.1186/s40816-017-0046-7"]}, {"Citation": "Vacheva A., Mustafa B., Staneva J., Marhova M., Kostadinova S., Todorova M., Ivanova R., Stoitsova S. Effects of Extracts from Medicinal Plants on Biofilm Formation by Escherichia coli Urinary Tract Isolates. Biotechnol. Biotechnol. Equip. 2011;25:92\u201397. doi: 10.5504/BBEQ.2011.0111.", "ArticleIdList": ["10.5504/BBEQ.2011.0111"]}, {"Citation": "\u017ditek T., Postru\u017enik V., Knez \u017d., Golle A., Dari\u0161 B., Knez Marevci M., Arnica Montana L. Supercritical Extraction Optimization for Antibiotic and Anticancer Activity. Front. Bioeng. Biotechnol. 2022;10:897185. doi: 10.3389/fbioe.2022.897185.", "ArticleIdList": ["10.3389/fbioe.2022.897185", "PMC9127360", "35620474"]}, {"Citation": "Hidalgo G., Chan M., Tufenkji N. Inhibition of Escherichia coli CFT073 fliC expression and motility by cranberry materials. Appl. Environ. Microbiol. 2011;77:6852\u20136857. doi: 10.1128/AEM.05561-11.", "ArticleIdList": ["10.1128/AEM.05561-11", "PMC3187111", "21821749"]}, {"Citation": "Ranfaing J., Dunyach-Remy C., Lavigne J.P., Sotto A. Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) in reducing the motility and the biofilm formation of uropathogenic Escherichia coli. PLoS ONE. 2018;13:e0202609. doi: 10.1371/journal.pone.0202609.", "ArticleIdList": ["10.1371/journal.pone.0202609", "PMC6107218", "30138443"]}, {"Citation": "Rosenberg S., Horowitz R., Coppenhagen-Glazer S., Pizov G., Elia A., Gofrit O.N., Ginsburg I., Pode D. Intravesical administration of green tea extract attenuates the inflammatory response of bacterial cystitis\u2013a rat model. BJU Int. 2014;114:601\u2013607. doi: 10.1111/bju.12544.", "ArticleIdList": ["10.1111/bju.12544", "24712880"]}, {"Citation": "Zhou S., Fan K.K., Gu L.F., Yu B.Y., Chai C.Z. Anti-inflammatory effects of Abelmoschus manihot (L.) Medik. on LPS-induced cystitis in mice: Potential candidate for cystitis treatment based on classic use. Chin. J. Nat. Med. 2022;20:321\u2013331. doi: 10.1016/S1875-5364(22)60140-7.", "ArticleIdList": ["10.1016/S1875-5364(22)60140-7", "35551768"]}, {"Citation": "Rafsanjany N., Lechtenberg M., Petereit F., Hensel A. Antiadhesion as a functional concept for protection against uropathogenic Escherichia coli: In vitro studies with traditionally used plants with antiadhesive activity against uropathognic Escherichia coli. J. Ethnopharmacol. 2013;145:591\u2013597. doi: 10.1016/j.jep.2012.11.035.", "ArticleIdList": ["10.1016/j.jep.2012.11.035", "23211661"]}, {"Citation": "Bortolami M., Di Matteo P., Rocco D., Feroci M., Petrucci R. Metabolic Profile of Agropyron repens (L.) P. Beauv. Rhizome Herbal Tea by HPLC-PDA-ESI-MS/MS Analysis. Molecules. 2022;27:4962. doi: 10.3390/molecules27154962.", "ArticleIdList": ["10.3390/molecules27154962", "PMC9370816", "35956912"]}, {"Citation": "Noundou X.S., Krause R.W., van Vuuren S.F., Ndinteh D.T., Olivier D.K. Antibacterial effects of Alchornea cordifolia (Schumach. and Thonn.) M\u00fcll. Arg extracts and compounds on gastrointestinal, skin, respiratory and urinary tract pathogens. J. Ethnopharmacol. 2016;179:76\u201382. doi: 10.1016/j.jep.2015.12.043.", "ArticleIdList": ["10.1016/j.jep.2015.12.043", "26724423"]}, {"Citation": "Lee K.C., Chang H.H., Chung Y.H., Lee T.Y. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-\u03baB pathway. J. Ethnopharmacol. 2011;135:678\u2013684. doi: 10.1016/j.jep.2011.03.068.", "ArticleIdList": ["10.1016/j.jep.2011.03.068", "21497192"]}, {"Citation": "de Arriba S.G., Naser B., Nolte K.U. Risk assessment of free hydroquinone derived from Arctostaphylos Uva-ursi folium herbal preparations. Int. J. Toxicol. 2013;32:442\u2013453. doi: 10.1177/1091581813507721.", "ArticleIdList": ["10.1177/1091581813507721", "24296864"]}, {"Citation": "Dietz B.M., Hajirahimkhan A., Dunlap T.L., Bolton J.L. Botanicals and Their Bioactive Phytochemicals for Women\u2019s Health. Pharmacol. Rev. 2016;68:1026\u20131073. doi: 10.1124/pr.115.010843.", "ArticleIdList": ["10.1124/pr.115.010843", "PMC5050441", "27677719"]}, {"Citation": "Venkatadri B., Arunagirinathan N., Rameshkumar M.R., Ramesh L., Dhanasezhian A., Agastian P. In vitro Antibacterial Activity of Aqueous and Ethanol Extracts of Aristolochia indica and Toddalia asiatica Against Multidrug-Resistant Bacteria. Indian J. Pharm. Sci. 2015;77:788\u2013791.", "ArticleIdList": ["PMC4778242", "26997710"]}, {"Citation": "Michl J., Jennings H.M., Kite G.C., Ingrouille M.J., Simmonds M.S., Heinrich M. Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach. J. Ethnopharmacol. 2013;149:235\u2013244. doi: 10.1016/j.jep.2013.06.028.", "ArticleIdList": ["10.1016/j.jep.2013.06.028", "23806867"]}, {"Citation": "Albrecht U., Goos K.H., Schneider B. A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections. Curr. Med. Res. Opin. 2007;23:2415\u20132422.", "ArticleIdList": ["17723159"]}, {"Citation": "Conrad A., Biehler D., Nobis T., Richter H., Engels I., Biehler K., Frank U. Broad spectrum antibacterial activity of a mixture of isothiocyanates from nasturtium (Tropaeoli majoris herba) and horseradish (Armoraciae rusticanae radix) Drug. Res. 2013;63:65\u201368. doi: 10.1055/s-0032-1331754.", "ArticleIdList": ["10.1055/s-0032-1331754", "23447075"]}, {"Citation": "Rajkumar J., Devi A.S., Beenish T.K. Detection of Antibacterial Compound of Avicennia marina Against Pathogens Isolated from Urinary Tract Infected Patients. Asian J. Chem. 2014;26:458\u2013460."}, {"Citation": "Wojnicz D., Kucharska A.Z., Sok\u00f3\u0142-\u0141\u0119towska A., Kicia M., Tichaczek-Goska D. Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli. Urol. Res. 2012;40:683\u2013697. doi: 10.1007/s00240-012-0499-6.", "ArticleIdList": ["10.1007/s00240-012-0499-6", "PMC3495101", "22915095"]}, {"Citation": "Sahu L., Jena S., Swain S.S., Sahoo S., Chand P.K. Agrobacterium rhizogenes-mediated transformation of a multi-medicinal herb, Boerhaavia diffusa L.: Optimization of the process and anti-microbial activity against bacterial pathogens causing urinary tract infections. Front. Life Sci. 2013;7:197\u2013209. doi: 10.1080/21553769.2013.879266.", "ArticleIdList": ["10.1080/21553769.2013.879266"]}, {"Citation": "Ferreres F., Sousa C., Justin M., Valent\u00e3o P., Andrade P.B., Llorach R., Rodrigues A., Seabra R.M., Leit\u00e3o A. Characterisation of the phenolic profile of Boerhaavia diffusa L. by HPLC-PAD-MS/MS as a tool for quality control. Phytochem. Anal. 2005;16:451\u2013458. doi: 10.1002/pca.869.", "ArticleIdList": ["10.1002/pca.869", "16315490"]}, {"Citation": "Adetutu A., Morgan W.A., Corcoran O. Ethnopharmacological survey and in vitro evaluation of wound-healing plants used in South-western Nigeria. J. Ethnopharmacol. 2011;137:50\u201356. doi: 10.1016/j.jep.2011.03.073.", "ArticleIdList": ["10.1016/j.jep.2011.03.073", "21501678"]}, {"Citation": "Yeboah G.N., Owusu F.W.A., Archer M.A., Kyene M.O., Kumadoh D., Ayertey F., Mintah S.O., Atta-Adjei Junior P., Appiah A.A. Bridelia ferruginea Benth.; An ethnomedicinal, phytochemical, pharmacological and toxicological review. Heliyon. 2022;8:e10366. doi: 10.1016/j.heliyon.2022.e10366.", "ArticleIdList": ["10.1016/j.heliyon.2022.e10366", "PMC9445295", "36082325"]}, {"Citation": "Vu\u010di\u0107 D.M., Petkovi\u0107 M.R., Rodi\u0107-Grabovac B.B., Stefanovi\u0107 O.D., Vasi\u0107 S.M., Comi\u0107 L.R. In vitro activity of heather [Calluna vulgaris (L.) Hull] extracts on selected urinary tract pathogens. Bosn. J. Basic Med. Sci. 2014;14:234\u2013238. doi: 10.17305/bjbms.2014.4.40.", "ArticleIdList": ["10.17305/bjbms.2014.4.40", "PMC4333975", "25428676"]}, {"Citation": "Vollmerhausen T.L., Ramos N.L., Dzung D.T., Brauner A. Decoctions from Citrus reticulata Blanco seeds protect the uroepithelium against Escherichia coli invasion. J. Ethnopharmacol. 2013;150:770\u2013774. doi: 10.1016/j.jep.2013.09.050.", "ArticleIdList": ["10.1016/j.jep.2013.09.050", "24120518"]}, {"Citation": "Duan L., Guo L., Dou L.L., Zhou C.L., Xu F.G., Zheng G.D., Li P., Liu E.H. Discrimination of Citrus reticulata Blanco and Citrus reticulata \u2018Chachi\u2019 by gas chromatograph-mass spectrometry based metabolomics approach. Food Chem. 2016;212:123\u2013127. doi: 10.1016/j.foodchem.2016.05.141.", "ArticleIdList": ["10.1016/j.foodchem.2016.05.141", "27374515"]}, {"Citation": "Uliana M.P., Silva A.G.D., Fronza M., Scherer R. In vitro Antioxidant and Antimicrobial Activities of Costus spicatus Swartz used in Folk Medicine for Urinary Tract Infection in Brazil. Latin. Am. J. Pharm. 2015;34:766\u2013772."}, {"Citation": "Chandra S., Gupta C.P. Antibacterial activity of medicinal plant Crateava nurvala (bark) against bacterial strains causing urinary tract infection. Asian J. Chem. 2001;13:1181\u20131186."}, {"Citation": "Bhattacharjee A., Shashidhara S.C. Aswathanarayana, Phytochemical and ethno-pharmacological profile of Crataeva nurvala Buch-Hum (Varuna): A review. Asian Pac. J. Trop. Biomed. 2012;2:S1162\u2013S1168. doi: 10.1016/S2221-1691(12)60379-7.", "ArticleIdList": ["10.1016/S2221-1691(12)60379-7"]}, {"Citation": "Packiavathy I.A., Priya S., Pandian S.K., Ravi A.V. Inhibition of biofilm development of uropathogens by curcumin\u2014An anti-quorum sensing agent from Curcuma longa. Food Chem. 2014;148:453\u2013460. doi: 10.1016/j.foodchem.2012.08.002.", "ArticleIdList": ["10.1016/j.foodchem.2012.08.002", "24262582"]}, {"Citation": "Pereira R.S., Sumita T.C., Furlan M.R., Jorge A.O., Ueno M. Antibacterial activity of essential oils on microorganisms isolated from urinary tract infection. Rev. Saude Publica. 2004;38:326\u2013328. doi: 10.1590/S0034-89102004000200025.", "ArticleIdList": ["10.1590/S0034-89102004000200025", "15122392"]}, {"Citation": "Sharma A., Verma R., Ramteke P. Cyperus rotundus: A potential novel source of therapeutic compound against urinary tract pathogens. J. Herb. Med. 2014;4:74\u201382. doi: 10.1016/j.hermed.2014.01.003.", "ArticleIdList": ["10.1016/j.hermed.2014.01.003"]}, {"Citation": "Zhang X., Yan Y., Lv Y., Li X., Chen L., Huang Z., Zhou J., Wang Y., Wang X., Wang X., et al. Dendrobium officinale polysaccharides attenuate uropathogenic Escherichia coli (UPEC)-induced pyroptosis in macrophage cells. Biomed. Pharmacother. 2022;151:113098. doi: 10.1016/j.biopha.2022.113098.", "ArticleIdList": ["10.1016/j.biopha.2022.113098", "35594714"]}, {"Citation": "L\u00fcthje P., Lokman E.F., Sandstr\u00f6m C., \u00d6stenson C., Brauner A. Gynostemma pentaphyllum exhibits anti-inflammatory properties and modulates antimicrobial peptide expression in the urinary bladder. J. Funct. Food. 2015;17:283\u2013292. doi: 10.1016/j.jff.2015.03.028.", "ArticleIdList": ["10.1016/j.jff.2015.03.028"]}, {"Citation": "Fazliana M., Ramos N.L., L\u00fcthje P., Sekikubo M., Holm A., Wan Nazaimoon W.M., Brauner A. Labisia pumila var. alata reduces bacterial load by inducing uroepithelial cell apoptosis. J. Ethnopharmacol. 2011;136:111\u2013116. doi: 10.1016/j.jep.2011.04.018.", "ArticleIdList": ["10.1016/j.jep.2011.04.018", "21524700"]}, {"Citation": "L\u00fcthje P., Dzung D.N., Brauner A. Lactuca indica extract interferes with uroepithelial infection by Escherichia coli. J. Ethnopharmacol. 2011;135:672\u2013677. doi: 10.1016/j.jep.2011.03.069.", "ArticleIdList": ["10.1016/j.jep.2011.03.069", "21497191"]}, {"Citation": "Kim K.H., Lee K.H., Choi S.U., Kim Y.H., Lee K.R. Terpene and phenolic constituents of Lactuca indica L. Arch. Pharm. Res. 2008;31:983\u2013988. doi: 10.1007/s12272-001-1256-8.", "ArticleIdList": ["10.1007/s12272-001-1256-8", "18787785"]}, {"Citation": "Ashraf K., Sultan S., Adam A. Orthosiphon stamineus Benth. is an Outstanding Food Medicine: Review of Phytochemical and Pharmacological Activities. J. Pharm. Bioallied. Sci. 2018;10:109\u2013118. doi: 10.4103/JPBS.JPBS_253_17.", "ArticleIdList": ["10.4103/JPBS.JPBS_253_17", "PMC6142889", "30237681"]}, {"Citation": "Elmahmood A.M., Ameh J.M. In vitro antibacterial activity of Parkia biglobosa (Jacq.) root bark extract against some microorganisms associated with urinary tract infections. Afr. J. Biotechnol. 2007;6:1272\u20131275."}, {"Citation": "Tamfu A.N., Roland N., Mfifen A.M., Kucukaydin S., Gaye M., Botezatu A.V., Duru M.E., Dinica R.M. Phenolic composition, antioxidant and enzyme inhibitory activities of Parkia biglobosa (Jacq.) Benth., Tithonia diversifolia (Hemsl) A. Gray, and Crossopteryx febrifuga (Afzel.) Benth. Arab. J. Chem. 2022;15:103675. doi: 10.1016/j.arabjc.2021.103675.", "ArticleIdList": ["10.1016/j.arabjc.2021.103675"]}, {"Citation": "Saeidi S., Amini Boroujeni N., Ahmadi H., Hassanshahian M. Antibacterial Activity of Some Plant Extracts Against Extended- Spectrum Beta-Lactamase Producing Escherichia coli Isolates. Jundishapur. J. Microbiol. 2015;8:e15434. doi: 10.5812/jjm.15434.", "ArticleIdList": ["10.5812/jjm.15434", "PMC4353063", "25793093"]}, {"Citation": "Mina C.N., Farzaei M.H., Gholamreza A. Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: A review. J. Tradit. Chin. Med. 2015;35:104\u2013109.", "ArticleIdList": ["25842736"]}, {"Citation": "Fri\u0161\u010di\u0107 M., Jerkovi\u0107 I., Marijanovi\u0107 Z., Dragovi\u0107 S., Hazler\u2005Pilepi\u0107 K., Male\u0161 \u017d. Essential Oil Composition of Different Plant Parts from Croatian Petasites albus (L.) Gaertn. and Petasites hybridus (L.) G.Gaertn., B.Mey. & Scherb. (Asteraceae) Chem. Biodivers. 2019;16:e1800531.", "ArticleIdList": ["30600899"]}, {"Citation": "Petrolini F.V., Lucarini R., de Souza M.G., Pires R.H., Cunha W.R., Martins C.H. Evaluation of the antibacterial potential of Petroselinum crispum and Rosmarinus officinalis against bacteria that cause urinary tract infections. Braz. J. Microbiol. 2013;44:829\u2013834. doi: 10.1590/S1517-83822013005000061.", "ArticleIdList": ["10.1590/S1517-83822013005000061", "PMC3910196", "24516424"]}, {"Citation": "Tintino S.R., Souza C., Guedes G., Costa J., Duarte F.M., Chaves M., Silva V.A., Pess\u00f4a H., Lima M.A., Garcia C.A. Modulatory antimicrobial activity of piper arboreum extracts. Acta Bot. Croat. 2014;73:281\u2013289. doi: 10.2478/botcro-2013-0026.", "ArticleIdList": ["10.2478/botcro-2013-0026"]}, {"Citation": "da Silva A.C.A., Matias E.F.F., Rocha J.E., Ara\u00fajo A.C.J., de Freitas T.S., Campina F.F., Costa M.D.S., Silva L.E., Amaral W.D., Maia B., et al. Gas chromatography coupled to mass spectrometry (GC-MS) characterization and evaluation of antibacterial bioactivities of the essential oils from Piper arboreum Aubl., Piper aduncum L. e Piper gaudichaudianum Kunth. Z. Naturforsch. C J. Biosci. 2021;76:35\u201342. doi: 10.1515/znc-2020-0045.", "ArticleIdList": ["10.1515/znc-2020-0045", "32673283"]}, {"Citation": "Liao S.G., Zhang L.J., Sun F., Zhang J.J., Chen A.Y., Lan Y.Y., Li Y.J., Wang A.M., He X., Xiong Y., et al. Antibacterial and anti-inflammatory effects of extracts and fractions from Polygonum capitatum. J. Ethnopharmacol. 2011;134:1006\u20131009. doi: 10.1016/j.jep.2011.01.050.", "ArticleIdList": ["10.1016/j.jep.2011.01.050", "21296143"]}, {"Citation": "Seifi M., Abbasalizadeh S., Mohammad-Alizadeh-Charandabi S., Khodaie L., Mirghafourvand M. The effect of Rosa (L. Rosa canina) on the incidence of urinary tract infection in the puerperium: A randomized placebo-controlled trial. Phytother. Res. 2018;32:76\u201383. doi: 10.1002/ptr.5950.", "ArticleIdList": ["10.1002/ptr.5950", "29024081"]}, {"Citation": "Peng M.M., Fang Y., Hu W., Huang Q. The pharmacological activities of Compound Salvia Plebeia Granules on treating urinary tract infection. J. Ethnopharmacol. 2010;129:59\u201363. doi: 10.1016/j.jep.2010.02.029.", "ArticleIdList": ["10.1016/j.jep.2010.02.029", "20211234"]}, {"Citation": "Liang Y.-Y., Wan X.-H., Niu F.-J., Xie S.-M., Guo H., Yang Y.-Y., Guo L.-Y., Zhou C.-Z. Salvia plebeia R. Br.: An overview about its traditional uses, chemical constituents, pharmacology and modern applications. Biomed. Pharmacother. 2020;121:109589. doi: 10.1016/j.biopha.2019.109589.", "ArticleIdList": ["10.1016/j.biopha.2019.109589", "31810130"]}, {"Citation": "Sittiwet C., Puangpronpitag D., Niamsa N. In vitro Antimicrobial Activity of Schefflera leucantha: The Potential of Respiratory Tract and Urinary Tract Infection Treatment. Int. J. Pharmacol. 2009;5:240\u2013243. doi: 10.3923/ijp.2009.240.243.", "ArticleIdList": ["10.3923/ijp.2009.240.243"]}, {"Citation": "Wang Y., Liang D., Khan F.-A., Zhang C.-L., Liu Y.-F., Chen R.-Y., Choudhary M.I., Yu D.-Q. Chemical constituents from Schefflera leucantha R.Vig. (Araliaceae) Biochem. Syst. Ecol. 2020;91:104076. doi: 10.1016/j.bse.2020.104076.", "ArticleIdList": ["10.1016/j.bse.2020.104076"]}, {"Citation": "Karunai Raj M., Balachandran C., Duraipandiyan V., Agastian P., Ignacimuthu S. Antimicrobial activity of Ulopterol isolated from Toddalia asiatica (L.) Lam.: A traditional medicinal plant. J. Ethnopharmacol. 2012;140:161\u2013165. doi: 10.1016/j.jep.2012.01.005.", "ArticleIdList": ["10.1016/j.jep.2012.01.005", "22265751"]}, {"Citation": "Mao X., Guo H., Yao R., Bao L., Sun J., Bao Y., Guo B., Gao Y., Shi Y., Zhang H., et al. Crude polysaccharides from the seeds of Vaccaria segetalis prevent the urinary tract infection through the stimulation of kidney innate immunity. J. Ethnopharmacol. 2020;260:112578. doi: 10.1016/j.jep.2020.112578.", "ArticleIdList": ["10.1016/j.jep.2020.112578", "31962152"]}, {"Citation": "Uzoigwe C.I., Agwa O.K. Antimicrobial activity of Vernonia amygdalina on selected urinary tract pathogens. Afr. J. Microbiol. Res. 2011;5:1467\u20131472. doi: 10.5897/AJMR10.866.", "ArticleIdList": ["10.5897/AJMR10.866"]}, {"Citation": "Sharma A., Chandraker S., Patel V.K., Ramteke P. Antibacterial Activity of Medicinal Plants Against Pathogens causing Complicated Urinary Tract Infections. Indian J. Pharm. Sci. 2009;71:136\u2013139. doi: 10.4103/0250-474X.54279.", "ArticleIdList": ["10.4103/0250-474X.54279", "PMC2839399", "20336211"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "5", "Day": "24"}, {"Year": "2023", "Month": "6", "Day": "20"}, {"Year": "2023", "Month": "6", "Day": "21"}, {"Year": "2023", "Month": "7", "Day": "17", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "14", "Hour": "13", "Minute": "8"}, {"Year": "2023", "Month": "7", "Day": "14", "Hour": "1", "Minute": "13"}, {"Year": "2023", "Month": "6", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["37445714", "PMC10341809", "10.3390/ijms241310537", "ijms241310537"]}}], "PubmedBookArticle": []}